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Chapter 1
Introduction and outline of the thesis
Adapted from: Innate immunity networks during infection with Borrelia burgdorferi. 
Crit Rev Microbiol. 2016 Mar;42(2):233-44. 
Marije Oosting, Kathrin Buffen, Jos W.M. van der Meer, Mihai G. Netea, Leo A.B. Joosten
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General introduction
Lyme disease, caused by spirochetes of the Borrelia burgdorferi sensu lato complex, 
is the most common vector-born disease in the northern hemisphere. The Centers for 
Disease Control and Prevention (CDC) reported over 300,000 cases of confirmed Lyme 
disease patients in the United States of America in 2013, whereas already 22,000 cases 
of erythema migrans (EM) were reported in the Netherlands in 2010.
Since the original description of the disease by Steere and co-workers in 1975 [1] and 
the discovery of the causative pathogen by Burgdorfer in 1982 [2], our knowledge of the 
etiology and pathogenesis of Lyme disease has increased tremendously. The first most-
common sign of infection manifest as early localized skin inflammation (EM), frequently 
accompanied by flu-like symptoms [3]. If treated correctly, the prognosis for these patient 
is excellent; however, if untreated, hematogenous dissemination of spirochetes may give 
rise to a wide range of clinical manifestations, involving the central nervous system (mainly 
caused by Borrelia garinii), the skin (Borrelia afzelii) or the joints (Borrelia burgdorferi). 
Although clinicians still have difficulties making the diagnosis, signs and symptoms of 
the infection are nowadays better recognized and this results in early antibiotic treatment 
in many patients. In approximately 10% of the patients symptoms may persist, despite 
antibiotic treatment [4]. To what extent the prolonged illness is due to persistent infection, 
persistent non-infectious inflammation or neither is controversial. Thus more insight 
into the pathogenesis of Lyme disease and its sequelae will help in the management of 
patients to develop novel treatment modalities in the future. 
Borrelia characteristics and early host defense
Borrelia burgdorferi, B. afzelii, and B. garinii are Gram-negative bacteria. The spirochetal 
flat-waved body of Borrelia has a typical coiled spiral shape, with lengths ranging from 
3 to 500 µM, and a diameter ranging from 0.09 to 0.75 µM [5]. This variation in diameter 
might be dependent on the environment where the spirochetes were originated, but not 
crucial for their pathogenic behavior. 
Ticks within the Ixodidae family inject the disease-causing bacteria into the host‘s 
bloodstream. Since Borrelia is sensitive to proteases that are released by the host [6-8] it 
expresses a variety of proteins on their outer surface that modulates the defense system 
of the host. One family of proteins expressed by Borrelia belongs to the outer surface 
proteins (OSP) family, of which OspA and OspC are best known. OspC is expressed 
during early stages of infection, and has recently been described to bind host plasminogen 
and thereby support dissemination of the Borrelia bacterium [9]. When OspC is bound to 
plasminogen, it is more difficult for the host defense system to recognize the pathogen. 
Recognition of Borrelia burgdorferi
The immune system of the host is able to react to pathogenic bacteria in a short 
timeframe with a wide area of different immune cells. Already in 1984 it was described 
that Borrelia could be recognized and phagocytosed by neutrophils and macrophages 
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[10]. In conjunction with phagocytosis, neutrophils are capable of eliminating Borrelia 
by oxidative burst, and release of lysosomal hydrolytic enzymes. Chemoattractants for 
polymorphonuclear (PMN) leukocytes have been detected in human synovial fluids from 
Borrelia-infected knee joints [11].
Cells of the immune system need to be activated before cytokines or chemokines can be 
produced. These activation mechanisms can be induced after the recognition of highly 
specific microbial ligands, so-called pathogen-associated molecular patterns (PAMPs), 
by pattern recognition receptors (PRRs). Several families of PRRs have been described, 
including Toll-like receptors (TLRs), Nod-like receptors (NLRs), C-type lectins (CTLs), 
and RigI-helicases. Numerous in vitro studies indicate the importance of lipid-modified 
proteins in the pathogenesis of the infection [12-14]. The immune system recognizes 
these lipoproteins by different pattern recognition receptors (PRRs), of which Toll-like 
receptor 2 (TLR2) and Nucleotide-binding oligomerization domain-containing protein 
2 (NOD2) are suggested to be the most important during the pathogenesis of Borrelia 
burgdorferi infection (Figure 1) [15, 16]. 
Role of extracellular receptors for Borrelia recognition - TLR1, TLR2, and TLR6 
The TLR-family comprises 11 human and 13 murine receptors. TLR1, TLR2, TLR4, 
TLR5, TLR6, and TLR10 are mainly found on the surface of cells whereas TLR3, TLR7, 
TLR8, and TLR9 are located intracellularly. TLR11 is nonfunctional in humans due to an 
early stop codon in the coding gene [17]. Each of the TLRs recognizes a specific set of 
microbial ligands.
By recognizing lipopeptides (e.g. OspA) from Borrelia species [18, 19], TLR2 represents 
a key recognition receptor present on immune cells [20]. Blockade of TLR2 leads to an 
abrogated immune response induced by Borrelia exposure in human primary cells [21]. 
Furthermore, variations in the human TLR2 gene appear to result in different clinical 
outcomes in Lyme disease [22]. 
TLR2 forms either homodimers, or heterodimers with TLR1 or TLR6. By interacting with 
co-receptors, TLR2 is able to recognize a broad range of microbial ligands, including 
peptidoglycans, lipopeptides and fungal polysaccharides [23]. Until recently, it was 
unclear whether Borrelia was recognized by either TLR1/2 or TLR2/6 heterodimers. By 
using RNA silencing approaches it was shown that TLR1, rather than TLR6, is important 
for the recognition of Borrelia by the host defense system [15, 24-26]. There is additional 
evidence that TLR1 and TLR2 are important in a murine model of Lyme disease. Wooten 
et al. demonstrated that higher spirochetal numbers were found in joints of TLR2-deficient 
mice 8 weeks after intradermal infection with live B. burgdorferi [22]. Higher amounts 
of Borrelia have also been observed in skin and bladder of TLR1/2 deficient mice after 
transmission of Borrelia via tick bites [27]. In addition, Borrelia-induced Lyme arthritis was 
significantly enhanced in mice missing TLR1 or TLR2, as demonstrated by increased 
local cell influx after OspA immunization or intradermal Borrelia injection [28, 29]. TLR1/2 
heterodimers are therefore crucial for the recognition and for controlling the outgrowth of 
Borrelia in vivo, as well as for Borrelia-induced inflammation.
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Role of intracellular receptors for Borrelia recognition – NOD2
NOD-like receptors (NLR) family members are a separate class of intracellular PRR. The 
major pattern recognition receptors within this family are the Nucleotide Oligomerization 
Domain (NOD) members 1 and 2, as well as the NLRP receptors that are involved in 
inflammasome activation. NOD1 is activated by muramyltripeptide (MTP), derived from 
Gram-negative bacteria, while NOD2 is activated by muramyldipeptide (MDP) from 
Gram-positive bacteria. After activation of either NOD1 or NOD2 by these bacterial 
moieties, activation of the adaptor molecule RICK finally leads to transcription of NFкB 
and production of pro- and anti-inflammatory cytokines (Figure 1).
It was long assumed that only the proteins on the outer surface of Borrelia cell wall are 
responsible for the induction of inflammatory mediators [22]. Oosting et al, however, 
demonstrated that although Borrelia is a Gram-negative organism, NOD2 is involved in 
Borrelia-induced cytokine responses of human PBMCs [21]. Individuals bearing a genetic 
polymorphism leading to a dysfunctional NOD2 molecule display a decreased cytokine 
production. In line with these data, murine BMDCs lacking NOD2 also produced less 
cytokines after live B. burgdorferi exposure [30]. In addition, the production of cytokines 
by synovial tissue explants of NOD2-deficient mice that were injected intraarticularly 
with live B. burgdorferi was reduced [31]. However, the inhibition of cytokine production 
was not complete, indicating that NOD2-independent signaling pathways are relevant. 
The NOD2-deficient BMDMs exposed to Borrelia also exhibit a downregulated type I 
interferon response [30], but the role of NOD2 for the type I interferon production is largely 
redundant [32]. 
Figure 1. Schematic overview of Borrelia-induced autophagy and its effect on cytokines. Borrelia bacteria are 
recognized through specific pattern recognition receptors, including Toll-like receptor 1/2 and NOD2. After activation, 
NF-κB is transcribed and cytokines, such as Il-1β are produced and secreted after activation by the inflammasome. In 
addition, B. burgdorferi induces autophagy, which regulates the production of inflammatory cytokines. 
1Introduction and outline of the thesis
11
Autophagy
In addition to the induction of intracellular signals leading to the production of cytokines, 
engagement of PRRs such as NOD2 activates autophagy, a process in which 
damaged organelles or long-lived proteins are degraded [33-36]. Autophagy involves 
the sequestration of dysfunctional proteins in a double-layered membrane called 
autophagosome, which is formed by the elongation of small membrane structures. The 
formation of the isolation membrane is initiated by several kinases as ULK1 and ULK2 
(which are mammalian homologues of the yeast autophagy-related protein 1 – ATG1) and 
the activity of type III phosphatidylinositol 3-kinase (PI3K) which forms a complex with 
beclin 1 (yeast ATG6) [37]. Further elongation and autophagosome completion requires 
different complexes of autophagy proteins as the ATG5-ATG12-ATG16L1 complex and 
the PE-conjugated microtubule-associated protein 1 light chain 3 (LC3) [38]. The delivery 
of dysfunctional proteins to the autophagosomes is regulated by autophagic adaptors 
such as p62 which can bind to the intracellular target as well as to LC3, which associates 
to the autophagosome after being processed [39]. Autophagosomes mature through 
fusion with lysosomes, leading to the breakdown of the protein content [40]. 
Borrelia-induced cytokines 
Proinflammatory cytokines play an important role in the pathogenesis of Lyme disease. 
Early during the infection, monocytes and macrophages that encounter live Borrelia, 
produce several pro-inflammatory cytokines, such as IL-1β, IL-6, IL-8 and TNF-α [25, 41-
44]. The mRNA coding for interleukin-1β can be detected as early as 1h after exposure 
to Borrelia in human cells. These cytokines activate phagocytes for the killing of the 
pathogens after recognition, and in addition attract other immune cells to the site of 
infection. The monocyte-derived cytokines also induce T lymphocyte polarization leading 
to production of interferon-γ (by T helper 1 lymphocytes) and IL-17 (by T helper 17 cells). 
In skin biopsies taken from patients presenting with an erythema migrans, high levels of 
pro-inflammatory cytokines including IFN-γ could be detected [45]. 
The role of IL-1β
IL-1β is one of the cytokines that is produced in high concentrations by both murine and 
human monocytes/macrophages after exposure to Borrelia species (Figure 2) [21, 43, 
46, 47]. Of interest IL-1β was detected in synovial fluid of Lyme arthritis patients at early 
time points [48]. Peptidoglycan from the cell wall of Borrelia is the main inducer of the 
production of IL-1β by murine macrophages [49]. Mice susceptible for the development 
of Lyme disease (C3H/HeN strain) were found to respond with high cytokine production 
when challenged with Borrelia spirochetes [50]. The development of murine Lyme arthritis 
is critically dependent on IL-1β as demonstrated in IL-1R deficient mice [31]. In patients 
with Lyme arthritis, whose arthritis was reactivated after antibiotic treatment it was shown 
that IL-1β concentrations were higher in synovial fluid and tissue than in patients that 
recovered from the antibiotic treatment [48]. Still, the exact role of IL-1β in the development 
of persistent Lyme disease is not fully understood. It is likely that at least part of the 
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pathogenic role of IL-1β in Lyme disease is mediated via the induction of a proper IL-17/
Th17 response against Borrelia spirochetes, with subsequent production of IL-22 [46]. 
IL-17 is a cytokine that plays an important role in the Th17-mediated responses and can 
amplify immune activation upon microbial recognition [46].
The role of IL-23, IL-17, IL-22, and IFN-γ
IL-23, IL-17, IL-22 and IFN-γ are produced after exposure of Borrelia to human peripheral 
blood mononuclear cells [25, 46, 51]. Production of IL-17 and IL-22 is under control of IL-
1β, and the naturally-occurring IL-1 receptor antagonist (IL-1Ra) inhibits the Th17-derived 
cytokine response [46]. In line with these data, IL-1β-deficient mice have a defective 
Th17 response [44]. IL-17 is important in the development of the Borrelia-antigen induced 
arthritis model as shown by experiments of Burchill et al, in which IL-17 blockade resulted 
in diminished joint inflammation [52, 53]. IFN-γ and IL-22 were detected in skin biopsies 
from individuals with erythema migrans [54], and IL-17 production was found in synovial 
cells from Lyme arthritis patients [55]. Patients with proven late neuroborreliosis exhibited 
higher IL-17 concentrations than patients with earlier stages of neuroborreliosis [56]. 
IL-23 signaling is needed for optimal Th17 development, and PBMCs isolated from healthy 
subjects bearing a SNP in IL-23R showed a significantly decreased IL-17 production 
when exposed to Borrelia. The presence of this IL-23R SNP was associated with a trend 
towards a lower frequency of chronic clinical symptoms in a cohort of Lyme patients [51].
 
Figure 2. Borrelia-induced cytokines. After recognition of Borrelia by host immune cells, induction of early (upper 
part) cytokines is induced. Each cytokine has a different function in the host immune response against this bacterium.
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Autophagy and Lyme disease
The link between autophagy and the innate defense mechanism has been made in several 
studies describing the connection between dysfunctional autophagy and autoinflammatory 
diseases [57-60]. It has been shown that inhibition of autophagy by chemical inhibitors 
of PI3 kinases leads to an enhanced production of extracellular IL-1β after stimulation 
with bacterial wall components such as LPS [61]. This observation, next to the fact that 
B. burgdorferi is thought to be recognized by the autophagy-inducing receptor NOD2, led 
to the investigation of the role of autophagy during infection with B. burgdorferi. It was 
shown that autophagy-blocked PBMCs stimulated with the Borrelia-spirochete secreted 
higher levels of IL-1β and IL-6 protein. In addition, the mRNA synthesis of IL-1β and IL-6 
was strongly increased as well, indicating that the inhibition of autophagy modulates IL-1β 
and IL-6 production at the transcriptional level (Figure 1) [62].
Furthermore, it has been shown that autophagy modulates the production of T-cell derived 
cytokines as IL-17, IL-22 and IFN-γ [63, 64], all cytokines known to be produced also after 
stimulation with B. burgdorferi [65, 66]. Since higher levels of IL-17 have been associated 
to increased joint damage in rheumatoid arthritis patients [67] and elevated IL-17 levels 
have been found in patients with confirmed neuroborreliosis [68], the role of autophagy 
on the production of T cell-derived cytokines in response to B. burgdorferi has been 
examined. It was shown that autophagy-blocked PBMCs stimulated with the Borrelia-
spirochete secreted higher levels of IL-17, IL-22 and IFN-γ protein [69], demonstrating 
a regulatory link between autophagy and T-cell cytokine production in response to B. 
burgdorferi stimulation, which was dependent on IL-1 but not on IL-23 secretion.
Outline of the thesis
In recent years, the knowledge of the Borrelia spirochete and Lyme disease has greatly 
increased. Considerable insight has been gained into how the encounter between the 
microorganism and the host leads to disease. Nevertheless, many aspects of the disease 
caused by Borrelia spirochetes remain unexplained, and the nature of the immune 
response against this bacterium is only partly understood. The aim of this thesis is to 
study the role of autophagy during the immune response against B. burgdorferi and to 
identify potential novel therapeutic targets for the treatment of Lyme disease. 
In Chapter 2 the signaling pathways – TLR2-Myd88 and NOD2-RICK – involved in 
the recognition of B. burgdorferi by immune cells and their effect on the induction of 
cytokines will be elucidated. The recognition of Borrelia results in the secretion of the pro-
inflammatory cytokine IL-1β which is known to be involved in the pathogenesis of Lyme 
disease [70-72]. IL-1β production requires two important steps: transcription of mRNA 
resulting in the production of proIL-1β protein, and cleavage of the immature precursor into 
mature bioactive IL-1β by the inflammasome-enzyme caspase-1 [73]. Therefore, the role 
of the NLRP3 inflammasome for Borrelia-induced Lyme arthritis will be explored. Several 
studies linked the activation of NOD2 to autophagy [74]. Autophagy is an intracellular 
mechanism that regulates degradation of old or damaged cell organelles without any 
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harmful effect on the cell itself. When autophagy is hampered or not functional due to 
a genetic defect, IL-1β production is strongly elevated after exposure to B. burgdorferi 
as shown in Chapter 3. IL-1β has a broad range of functions as mediating inflammation 
and providing protective immunity to infectious diseases. In synergy with IL-23, it induces 
the production of IL-17 which has been associated with increased joint damage in 
patients with rheumatoid arthritis [67]. In Chapter 4 the role of autophagy in a knockout 
mouse model of Lyme arthritis will be illustrated, followed by the effect of autophagy on 
Borrelia-induced adaptive cytokines. The autophagy machinery depends on specialized 
autophagy-related proteins (ATGs). To identify the key players of autophagy, which 
are modulated by stimulation with the Borrelia spirochete, transcriptional analysis and 
functional genomics will be performed in Chapter 5. 
In recent years, emerging evidence has shown that after infection or vaccination, innate 
immune cells display long-term changes in their functional programs. These changes lead 
to increased production of inflammatory mediators and enhanced capacity to eliminate 
infection. In Chapter 6 the role of autophagy in trained immunity will be investigated, 
demonstrating a possible protective role for future infections with B. burgdorferi. 
A summary of the new findings and conclusions of this thesis are presented in Chapter 7. 
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Abstract
The protein platform called the Nod-Like-Receptor-family member (NLRP)-3 
inflammasome needs to be activated to process intracellular caspase-1. Active caspase-1 
is able to cleave pro-Interleukin (IL)-1β, resulting in bioactive IL-1β. IL-1β is a potent pro-
inflammatory cytokine, and thought to play a key role in the pathogenesis of Lyme arthritis, 
a common manifestation of Borrelia burgdorferi infection. The precise pathways through 
which B.burgdorferi recognition leads to inflammasome activation and processing of IL-
1β in Lyme arthritis has not been elucidated. In the present study, we investigated the 
contribution of several pattern recognition receptors and inflammasome components in a 
novel murine model of Lyme arthritis.
Lyme arthritis was elicited by live B.burgdorferi, injected intraarticularly in knee joints of 
mice. To identify the relevant pathway components, the model was applied to wild-type, 
NLRP3-/-, ASC-/-, caspase-1-/-, NOD1-/-, NOD2-/-, and RICK-/- mice. As a control, TLR2-
/-, Myd88-/- and IL-1R-/- mice were used. Peritoneal macrophages and bone marrow-
derived macrophages were used for in vitro cytokine production and inflammasome 
activation studies. Joint inflammation was analyzed in synovial specimens and whole 
knee joints. Mann-Whitney U tests were used to detect statistical differences.
We demonstrate that ASC/caspase-1-driven IL-1β is crucial for induction of B.burgdorferi-
induced murine Lyme arthritis. In addition, we show that B.burgdorferi-induced murine 
Lyme arthritis is less dependent on NOD1/NOD2/RICK pathways while the TLR2-MyD88 
pathway is crucial. 
Murine Lyme arthritis is strongly dependent on IL-1 production, and B. burgdorferi induces 
inflammasome-mediated caspase-1 activation. Next to that, murine Lyme arthritis is ASC 
and caspase-1-dependent, but NLRP3, NOD1, NOD2, and RICK independent. Also, 
caspase-1 activation by B. burgdorferi is dependent on TLR2 and MyD88. Based on 
present results indicating that IL-1 is one of the major mediators in Lyme arthritis, there 
is a rationale to propose that neutralizing IL-1 activity may also have beneficial effects in 
chronic Lyme arthritis.
Chapter 2
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Introduction
 
Lyme disease is a complex infectious disease, caused by spirochetes of the Borrelia 
burgdorferi sensu lato family. The initial host response towards Borrelia is mediated by the 
innate immune system through recognition by pattern recognition receptors (PRRs) [1-3]. 
Toll-like receptor 2 (TLR2) recognizes Borrelia species. Cells from TLR2-deficient mice 
show decreased cytokine production after exposure to Borrelia species [4], and infection 
with live B.burgdorferi in these mice results in up to 100-fold more spirochetes in their 
joints [5]. Cells of humans bearing a single nucleotide polymorphism (SNP) in their TLR2 
gene show reduced cytokine production when exposed to Borrelia derived antigens [6]. 
Furthermore, we and others have found that TLR1/2, but not TLR2/6, heterodimers are 
essential for B.burgdorferi-dependent cytokine production [7, 8]. The crucial role for a 
TLR-mediated pathway was further underlined by studies using MyD88 gene deficient 
mice [9, 10]. When Myd88-deficient mice were injected with live B.burgdorferi, highly 
elevated spirochetal burden was found in several organs of the mice, indicating the 
pivotal role of Myd88 in innate host defense against Borrelia [11].
B.burgdorferi is recognized by the intracellular receptor nucleotide-binding oligomerization 
domain-containing protein 2 (NOD2), a member of the NLR family. Recently, it was 
demonstrated that NOD2 is needed for optimal cytokine production after B.burgdorferi 
stimulation in mice, but does not affect the spirochetal burden [12]. Cells from humans 
bearing the NOD2 frameshift mutation produced less IL-1β when exposed to B.burgdorferi, 
indicating that this PRR is also important in Lyme disease [3]. 
The pro-inflammatory cytokine interleukin (IL)-1β is known to play a major role in the 
pathogenesis of Lyme arthritis [13-15]. Synthesis of its inactive precursor pro-IL-1β 
is initiated by signals induced through PRRs [16], processing of pro-IL-1β to yield the 
active cytokine requires cleavage by caspase-1 [17]. In turn, caspase-1 activation needs 
assembly of a protein platform known as the inflammasome, of which the NLR-family 
member NLRP3 is the most studied [18]. 
In the present study, we explored the signaling pathways involved in recognition 
of B.burgdorferi by immune cells and their effect on the induction of cytokines. We 
investigated the two major recognition pathways for B.burgdorferi, TLR2-MyD88 and 
NOD2-RICK in the induction of Lyme arthritis. In addition, the role of components of the 
NLRP3 inflammasome for Borrelia-induced Lyme arthritis was explored. 
Methods
Borrelia burgdorferi cultures. B.burgdorferi ATCC strain 35210, was cultured at 33°C in 
Barbour-Stoenner-Kelley (BSK)-H medium (Sigma-Aldrich) supplemented with 6% rabbit 
serum. Spirochetes were grown as described by Oosting et al [19].
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Animals. IL-1R knockout mice were from Jackson Laboratories (B6.129S7-Il1r1tm1Imx/J). 
Female wild-type (C57Bl/6J) and knock-out mice between 8-10 weeks of age were used. 
The mice were fed sterilized laboratory chow (Hope Farms, Woerden, The Netherlands) 
and water ad libitum. The protocol was approved by the Ethics Committee on Animal 
Experiments of the Radboud University Nijmegen Medical Centre (RU-DEC-2011-013). 
MyD88-/-, TLR2-/-, NOD1-/-, NOD2-/-, RICK-/-, ASC-/-, NLRP3-/-, and caspase-1-/- mice 
were bred and maintained in the St. Jude Children’s Research Hospital, Memphis, TN, 
USA, as previously described [4, 20-25]. Female wild-type (C57Bl/6J) and knock-out mice 
between 8-10 weeks of age were used. Animal studies were conducted under protocols 
approved by St. Jude Children’s Research Hospital Committee on Use and Care of Animals.
In vitro cytokine production. Bone marrow was isolated according to Oosting et al 
[19]. For stimulation of BMDMs and cytokine measurements, see additional file 3, 
supplementary text. 
Western blot. Western Blot analysis was performed according to the procedure described 
by Oosting et al. [19].
Induction of Borrelia-induced joint inflammation and histology. Joint inflammation 
was induced by intra-articular injection (i.a.) of 1x107 live B.burgdorferi in 10µL of PBS 
into the right knee joint of naïve or knock-out mice. 4 hours after i.a. injection, mice were 
sacrificed and synovial specimens were isolated. After 24h, knee joints were removed 
for histology. Before removal of the joints, macroscopic score of the thickness of the 
joints (without skin) was performed ranging from no swelling (score is 0) or very severely 
swollen joints (score is referred as 3). Whole knee joints were removed and fixed in 
4% formaldehyde for 7 days before decalcification in 5% formic acid and processing for 
paraffin embedding. Histology of 7 µM knee sections was performed as described before 
[19].
RNA isolation and real-time quantitative PCR. RNA from mouse cells was isolated 
using TRIzol reagent (Invitrogen) following the manufacturer’s instructions. Isolated RNA 
was reversed transcribed into complementary DNA using iScript cDNA synthesis kit (Bio-
Rad Laboratories, Veenendaal, the Netherlands). See additional file 3, supplementary 
text for quantitative real-time PCR. 
Isolation of patella biopsies and patella washout assays. After resection of the 
patella with surrounding tissue, biopsies for mRNA expression assays were isolated 
using 3-mm disposable biopsy punches (Miltex, Integra, Germany) and immediately after 
isolation frozen in liquid nitrogen. Samples were stored at -80°C until RNA was extracted 
according to the method described above. Before RNA isolation, biopsies were lysed 
using the MagNALyser (Roche Applied Science, Germany). Patella washout assays were 
performed as described before [19].
Statistical Analysis. The data are expressed as mean ± SEM. Differences between 
experimental groups were tested using the two-sided Mann-Whitney U test performed on 
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GraphPad Prism 4.0 software (GraphPad). P values of ≤0.05 were considered significant.
Results
Induction of murine Lyme arthritis by intraarticular injection of live B.burgdorferi. 
Infection of C3H/HeN mice is a standard model for Lyme arthritis. C3H/HeN mice are 
highly susceptible to develop severe Lyme arthritis upon intradermal injection with 
Borrelia. C57Bl/6 mice are known to develop only mild symptoms caused by Borrelia 
species [26]. To induce murine Lyme arthritis in C57Bl/6 mice, we have used several 
application routes, ranging from intraperitoneal, intravenous, and intradermal in the lower 
back. However, none of these injection routes resulted in the development of detectable 
arthritis in wild-type C57/Bl6 mice (data not shown). In addition, we performed studies 
with dose-ranges up to 1x107 spirochetes per injection. No signs of Borrelia-induced joint 
inflammation were seen in the C57/Bl6 mice (data not shown). 
It has been demonstrated in patients with Lyme arthritis that Borrelia spirochetes were 
detected in synovial-fluid or -tissue using either PCR or culture [27, 28]. Therefore, we 
injected live Borrelia directly into knee joints of C57Bl/6 mice to mimic the clinical practice 
of patients with active Lyme arthritis. We were able to induce joint inflammation resulting 
in joint swelling and cell influx into the joint cavity up to day 7 after intra articular (i.a.) of 
spirochetes (Figure 1A/B). Using this novel model of Lyme arthritis we could address the 
goal of the current study, to investigate the upstream mediators of Borrelia burgdorferi-
induced activation of the inflammasome and the contribution of individual components of 
the inflammasome in Lyme arthritis.
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Figure 1. Murine Lyme arthritis is IL-1 dependent. (A) Macroscopic score of the knees in either wild-type (white 
bars), or IL-1Receptor-/- mice (black bars). After 4, 24, and 48 hours of intra-articular injection of 1x10^7 live 
B.burgdorferi, at least 10 knees per group. Data are mean±SEM from 8 animals in each group; ***p<0.0001; Mann–
Whitney U test, two-tailed.  (B) Murine Lyme arthritis in WT, or IL-1R-/- mice. Histology (H&E staining) 24, and 48
hours after i.a. injection of B.burgdorferi in knee joints. 200x magnification; P, patella; F, femur; JC, joint cavity; SL,
synovial lining. Scale bar represents 100 µM. (C) Upper left: Scored cell influx after 24 and 48 hours of i.a. injection
with B.burgdorferi. Upper right and lower left: 4 hours after i.a. injection of 1x10^7 live B.burgdorferi in 10 µL of PBS, 
patellae were cultured for 1h and IL-1β, IL-6 and KC protein levels and mRNA expression levels were measured
using Luminex and qPCR, respectively. Lower right: After 24 hours of infection, 1x10^5 peritoneal macrophages were
stimulated for 24 hours with live B.burgdorferi. White bars represent cytokine induction by wild-type mice, black bars
are IL-1R gene deficient mice, at least 5 animals/group. *p<0.05, **p<0.01; Mann-Whitney U-test, two-sided.
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Murine Lyme arthritis is strongly dependent on IL-1 production. IL-1 was shown 
already to play an important role in the pathogenesis of Lyme disease, but the role in the 
development of murine Lyme arthritis was never been described so far [15]. To corroborate 
the role of IL-1 in the induction of our novel murine model of Lyme arthritis, IL-1R-deficient 
mice were injected intraarticularly (i.a.) with live B.burgdorferi. Compared to wild-type 
mice, IL-1R-/- mice exhibited significantly reduced joint swelling at early (4h) and late 
(48h) time points (Figure 1A). This was reflected by histology: IL-1R gene deficient mice 
displayed a considerable reduction in the numbers of inflammatory cells in the joint cavity 
when compared to wild-type mice (Figure 1B). At 24h and 48h after induction of Lyme 
arthritis, the cell influx was decreased in IL-1R-/- mice (Figure 1C, upper left). In these 
mice, significantly reduced protein concentrations of IL-1β and the chemokine KC were 
found in patella washouts (Figure 1C, upper right). Synovial tissue explants of IL-1R-/- 
mice showed less IL-1β, and IL-6 mRNA expression, 4 hours after induction of Lyme 
arthritis (Figure 1C, lower left). KC mRNA expression was found to be similar between 
wild-type and IL-1R-/- mice (Figure 1C, lower left). No differences between wild-type 
and IL-1R knockout mice were observed in IL-1β, IL-6, and KC production of peritoneal 
macrophages stimulated with B.burgdorferi (Figure 1C, lower right). 
Borrelia-induced IL-1β production is NOD1/2 and RICK independent. In humans, 
B.burgdorferi-induced IL-1β was partly NOD2-dependent, but the role of this PRR in the 
development of arthritis was never been demonstrated. The roles of murine NOD1, NOD2, 
and RICK were explored using mouse cells. BMDMs isolated from wild-type, NOD1, 
NOD2, or RICK deficient mice were stimulated with either medium or B.burgdorferi. A 
clear induction of mRNA coding for IL-1β was seen in wild-type BMDMs upon stimulation 
with B.burgdorferi (Additional file 1, Figure S1). Surprisingly, NOD1, NOD2, and RICK 
appeared not to be important for the induction of IL-1β after B.burgdorferi recognition, 
whereas – as expected – TLR2 and MyD88 were (Figure 2A). In the absence of NOD1, 
IL-1β mRNA as well as IL-1β protein levels were higher than in cells of wild-type mice, 
indicating an inhibitory role of NOD1 in B.burgdorferi-induced IL-1β production (Additional 
file 1 and 2, Figure S1 and S2A). The IL-1 induced by BMDMs was bioactive in the IL-2 
induction assay (Figure 2B). NOD1-, NOD2- and RICK-deficient cells induced IL-6 and 
TNF-α production after exposure to B.burgdorferi (Additional file 1, Figure S1).
TLR2 and MyD88 mediated pathways are crucial for the Borrelia-induced IL-1β 
production. BMDMs isolated from wild-type, TLR2-/-, and MyD88-/- mice were exposed 
to either medium or B.burgdorferi. TLR2 and MyD88 are not only crucial for the induction 
of IL-1β-mRNA, but also important for the B.burgdorferi-induced IL-1β protein secretion in 
the supernatant (Additional file 1, Figure S1, and Additional file 2, Figure S2A). 
The IL-1β induced by BMDMs from wild-type mice was bioactive in the IL-2 assay, whereas 
no bioactive IL-1 production was seen by BMDMs of TLR2-/- and MyD88-/- mice (Figure 
2B). In line with previous results, TLR2 and MyD88 are also critical for B.burgdorferi-
induced IL-6 and TNF-α production on both protein as mRNA level (Additional file 1, 
Figure S1B/C).
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Caspase-1 activation by B.burgdorferi is dependent on TLR2 and MyD88. Inactive 
pro-caspase-1 needs to be cleaved to yield active caspase-1 before it can process pro-
IL-1β. To identify the signaling cascades involved in B.burgdorferi-induced caspase-1 
activation, BMDMs of TLR2-, MyD88-, NOD1-, NOD2-, or RICK-deficient mice were 
exposed to either medium (control) or B.burgdorferi plus ATP. Thereafter, Western 
Blot analysis was performed using a specific antibody detecting the active subunit of 
caspase-1. Wild-type cells stimulated with B.burgdorferi and ATP expressed the cleaved 
caspase-1 (Figure 2C). Surprisingly, activation of caspase-1 in BMDMs by B.burgdorferi 
is entirely dependent on TLR2 and Myd88 mediated pathways, whereas NOD1, NOD2, 
and RICK signaling pathways are not required for caspase-1 activation (Figure 2C).
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Figure 2. TLR2 and MyD88 drive -induced IL-
1β production. (A) 0.5x10^6 BMDMs from wild-type (WT), 
TLR2-/-, MyD88-/-, NOD1-/-, NOD2-/-, and RICK-/- mice 
were stimulated for 24 hours with either medium (Med), or 
5x10^6 spirochetes per mL live  (black bars. 
IL-1β protein levels in supernatant expressed in picograms 
per mL after BMDM exposure for 24 hours to B.burgdorferi. 
BMDMs are isolated from at least 5 animals per group, 
protein measurements were performed in duplicates. 
(B) IL-2 protein levels in nanograms per mL after BMDM 
stimulation with medium (Med), or 5x10^6 B.burgdorferi 
per mL for 24 hours, using cells from different knockout 
mice. (C) 3x10^6 Bone marrow derived macrophages from 
5 WT C57Bl/6, TLR2-/-, MyD88-/-, NOD1-/-, NOD2-/-, or 
RICK-/- mice were incubated for 24 hours with or without 
1x10^6 B.burgdorferi with ATP (3mM) for 30 minutes. 
Cleaved caspase-1 was detected by Western Blotting using 
antibodies to detect the inactive caspase-1 (p45) or active 
caspase-1 (p20). The control conditions were already 
published in an earlier article by our group [19]. Borrelia and 
ATP by itself are unable to induce caspase-1 activation, the 
combination of the two are crucial for inducing cleavage.
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B.burgdorferi induces murine Lyme arthritis through TLR2 and MyD88. As described 
before, both TLR2 and MyD88 play a critical role in B.burgdorferi-induced caspase-1 
activation and subsequent IL-1β production in vitro. To assess the roles of these molecules 
in vivo, we induced Lyme arthritis by injecting live B.burgdorferi spirochetes into knee 
joints of wild-type, TLR2-, or MyD88-deficient mice. In addition, we investigated NOD1, 
NOD2, and RICK knockout mice. Lyme arthritis, detected as joint swelling of the injected 
knee, could be clearly seen in wild-type mice. Both TLR2- and MyD88-deficient mice 
displayed significantly less joint swelling 4 hours after induction of Lyme arthritis (Figure 
3A). The lack of joint swelling was still noticeable after 24 hours (Figure 3A). Interestingly, 
NOD1 knockout mice displayed severe swelling, similar to that seen in wild-type mice. 
The expression of Lyme arthritis in NOD2 and RICK knockout mice was significantly 
lower than in wild-type animals, both at early (4h) and late (24h) phases (Figure 3A). 
Next to joint swelling, the cell influx into the joint cavity at 24h was assessed. In wild-type 
mice, the synovial lining was thickened and more cells, mainly neutrophils infiltrated into 
the joint cavity (Figure 3B and 3C). In both TLR2-, and MyD88-gene deficient mice the 
synovial lining was less inflamed and significant reduced cell influx could be observed 
(Figure 3B and 3C). 
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Figure 3. B.burgdorferi-induced murine Lyme arthritis is dependent on TLR2 and MyD88. (A) Macroscopic 
score of the knees in WT, TLR2ko, MyD88ko, NOD1ko, NOD2ko, and RICKko mice. After 4 hours and 24 hours of 
intra-articular injection of 1x10^7 live B.burgdorferi, at least 10 knees per group. Data are mean±SEM from 10 knees 
in each group; **p<0.01; ***p<0.0001, Mann–Whitney U test, two-tailed. (B) Scored cell influx 1 day after i.a. injection 
of B.burgdorferi. Data are mean±SEM from 10 knees in each group; **p<0.01; Mann–Whitney U test, two-tailed.  (C) 
Murine Lyme arthritis in WT, TLR2ko, MyD88ko, NOD1ko, NOD2ko, and RICKko mice. Histology (H&E staining) 1 
day after i.a. injection of B.burgdorferi in knee joints. 200x magnification; P, patella; F, femur; JC, joint cavity; SL, 
synovial lining. Scale bar represents 100 µM.
30
Inflammasome-mediated activation of caspase-1 by B.burgdorferi. The roles of 
inflammasome components ASC, and NLRP3 in the B.burgdorferi-induced caspase-1 
activation were assessed. Caspase-1 activation could be clearly detected when BMDMs 
of wild-type mice were exposed to B.burgdorferi, but was completely absent in cells 
from mice deficient in NLRP3, ASC, or caspase-1 (Figure 4A). Subsequently, NLRP3, 
ASC, and caspase-1 are crucial for total IL-1β protein production after B.burgdorferi 
stimulation (Figure 4B). Interestingly, a significantly decreased concentration of bioactive 
IL-1 could be observed in absence of ASC, NLRP3, or caspase-1, as compared to wild-
type mice (Figure 4C). Transcription of IL-1β mRNA was not influenced by deficiency 
of the inflammasome components after B.burgdorferi stimulation of BMDMs (Additional 
file 2, Figure S2A). No differences in mRNA and protein levels of both IL-6 and TNF-α 
could be detected between wild-type, ASC-, NLRP3- or caspase-1-deficient BMDM after 
stimulation with B.burgdorferi (Additional file 2, Figure S2B/C). 
Murine Lyme arthritis is ASC and caspase-1-dependent, but NLRP3 independent. To 
assess the role of the inflammasome components in vivo, wild-type (WT) mice, NLRP3-/-, 
ASC-/-, and caspase-1-/- mice were injected with live B.burgdorferi and joint swelling was 
assessed after 4 and 24 hours (Figure 5A). ASC and caspase-1 knockout mice showed 
significantly reduced joint swelling after local B.burgdorferi injection, whereas NLRP3-
gene deficient mice displayed joint inflammation similar to wild-type animals (Figure 5A). 
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Figure 4. Inflammasome components are necessary for 
B.burgdorferi-induced IL-1β. (A) 3x10^6 BMDMs from wild-
type, NLRP3-, ASC-, and caspase-1-gene deficient mice were 
stimulated for 24 hours with or without 1x10^6 B.burgdorferi
with ATP (3mM) for 30 minutes. Cleaved caspase-1 was
detected by Western Blotting using antibodies to detect the
inactive caspase-1 (p45) or active caspase-1 (p20). (B) IL-1β 
protein levels in the supernatant expressed in picograms per
milliliter after BMDM exposure for 24 hours to B.burgdorferi,
using WT, NLRP3-, ASC-, or caspase-1-gene deficient mice. 
BMDMs are isolated from at least 5 animals per group, protein 
measurements were performed in duplicates. (C) IL-2 protein 
levels in nanograms per mL after BMDM stimulation with
medium (Med), or 5x10^6 B.burgdorferi per mL for 24 hours,
using cells from different knockout mice. 
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ASC and caspase-1 knockout mice had also less thickened synovial linings than WT 
animals, and less cell influx into the joint cavity could be observed in these mice (Figure 
5B/C). Of interest, NLRP3 is not critical in the induction of murine Lyme arthritis.
NLRP3-independent local cytokine production after B.burgdorferi injection. The 
strong reduction of arthritis was in line with the findings that the local cytokine production 
was ablated in both TLR2-, and MyD88-deficient mice (Figure 6). Synovial tissue explants 
revealed that both the mRNA expression as the protein production of IL-1β, IL-6, and 
KC was almost absent in TLR2 and MyD88 knockout mice (Figure 6A/C). A remarkable 
finding was the fact that NOD1, NOD2, and RICK signaling does not seem to be involved 
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Figure 5. ASC and caspase-1- dependent role in murine Lyme arthritis. (A) Macroscopic score of the knees in 
WT, NLRP3, ASC, and caspase-1 knockout mice. After 4 hours and 24 hours of intra-articular injection of 1x10^7 live 
B.burgdorferi, at least 10 knees per group. Data are mean±SEM from 10 knees in each group; **p<0.01; ***p<0.0001; 
Mann–Whitney U test, two-tailed. (B) Scored cell influx 1 day after i.a. injection of B.burgdorferi. Data are mean±SEM 
from 10 knees in each group; *p<0.05; Mann–Whitney U test, two-tailed. (C) Murine Lyme arthritis in WT, NLRP3, 
ASC, and caspase-1 knockout mice. Histology (H&E staining) 1 day after i.a. injection of B.burgdorferi in knee joints. 
200x magnification; P, patella; F, femur; JC, joint cavity; SL, synovial lining. Scale bar represents 100 µM.
32
in the cell influx as similar numbers of inflammatory cells were found in the joint cavity as 
in wild-type mice (Figure 3B). This is in sharp contrast to the strongly reduced synovial 
production of IL-6, and KC in NOD1-/-, NOD2-/-, and RICK-/- mice, although NOD1 
deficient mice produced similar amounts of IL-1β as wild-type mice and NOD2-/- and 
RICK-/- mice showed only 50% reduction in IL-1β (Figure 6). The inhibitory effect of 
NOD1 seen in figure 3 for Borrelia-induced IL-1β production could not be observed using 
BMDM stimulation.
Next, we examined the local cytokine production in patellae after injection of B.burgdorferi. 
Levels of IL-1β, IL-6, and KC mRNA expression in synovial tissue of ASC and caspase-1 
deficient mice was found to be significantly lower, with exception of NLRP3 deficient mice 
as compared to wild-type mice (Figure 6A). Similar results were observed for synovial IL-6 
and KC mRNA expression (Figure 6B/C). Cytokine measurements in patella washouts 
showed that IL-1β production by the inflamed synovium was dependent on ASC and 
caspase-1, but not on NLRP3 (Figure 6A). This was also true for induction of IL-6, and 
KC (Figure 6B/C). Both ASC and caspase-1 are pivotal components for the induction of 
the latter cytokines. 
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Discussion
In the present study, we describe for the first time the role of TLR2 and MyD88 in vivo 
in a murine model of Lyme arthritis elicited by local injection of B.burgdorferi. TLR2 and 
MyD88 are crucial for B.burgdorferi-dependent caspase-1 activation and subsequent IL-1β 
production in vitro by bone marrow-derived macrophages. Mice deficient in TLR2 or MyD88 
display less joint swelling after intra-articular injection of B.burgdorferi and fewer cells 
are attracted towards the joint cavity. In addition to TLR2 and MyD88, the inflammasome 
components ASC and caspase-1 are essential for IL-1β production by B.burgdorferi-
stimulated BMDMs in vitro, and also are pivotal in the development of murine Lyme arthritis. 
The NOD1/NOD2/RICK pathway is also involved in synovial cell activation by B.burgdorferi, 
but is not essential for the production of IL-1β and for the influx of inflammatory cells into 
the joint cavity.
It is known that genetic background of mice influences the susceptibility for several 
experimental disease models [29, 30]. This holds also true for the induction and 
maintenance of experimental murine Lyme Disease. C3H/HeN mice are highly susceptible 
to develop severe arthritis upon intradermal injection with Borrelia. However, these C3H/
HeN mice also display a defect in IL-12 production and therefore lack IL-12/IL-18 induced 
IFN-γ production upon stimulation with pathogens [31]. This is in contrast to cells from 
C57Bl/6 mice which produce IFN-γ after Borrelia exposure [19]. This might explain the 
susceptibility of the C3H/HeN mice to the development of Lyme arthritis. Lacking IFN-γ 
production results in less killing of invading Borrelia bacteria, resulting in dissemination 
through the body. In our study, we used C57Bl/6 mice, which do not display any defects 
in immune responses and therefore will reflect the disease development in humans more 
appropriate.
It has been suggested earlier [15], that IL-1 is a key player in the pathogenesis of 
Lyme arthritis. Patients with Lyme arthritis who were found to have elevated synovial 
concentrations of IL-1Receptor antagonist (IL-1Ra) in combination with low concentrations 
of IL-1β showed a rapid resolution of Lyme arthritis. These data are in line with the results 
of the present study in murine Lyme arthritis. Mice deficient for the IL-1 receptor showed 
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Figure 6. TLR2 and MyD88 dependent and NLRP3 independent local cytokine production in synovium.  (A) IL-
1β mRNA expression and protein levels, IL-6 mRNA expression and protein (B), or KC mRNA expression and protein 
(C),  in biopsies isolated from synovial tissues from either wild-type, TLR2-, MyD88-, NOD1-, NOD2-, RICK-, NLRP3-, 
ASC-, and caspase-1-gene deficient mice. 4 hours after intra-articular injection with 1x10^7 live B.burgdorferi. At 
least 5 animals per group, bars represent mean±SEM; *p<0.05; **p<0.01; ***p<0.0001, Mann-Whitney U-test, two-
sided. (A-C Right panels) Four hours after intra-articular (i.a.) injection of 1x10^7 live B.burgdorferi in 10 mL of PBS, 
patellae from 5 WT C57BL/6 mice or knockout mice were cultured for 1h and IL-1β (A), IL-6 (B), and KC (C) levels 
were measured using Luminex. Data are represented as mean±SEM; 5 animals in each group; **p<0.01, ***p<0.001; 
Mann–Whitney U test, two-tailed.Scale bar represents 100 µM.
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significantly attenuated B.burgdorferi-induced arthritis. In addition, decreased levels of 
IL-1β were noted in mice without functional IL-1R. Both mRNA expression and protein 
concentrations of IL-1β were lower in synovial cells lacking IL-1R, when compared to 
wild-type mice. These findings point towards an amplification loop in the local production 
of IL-1β via its receptor during the onset of Lyme arthritis.
Before active IL-1β can be secreted, the inflammasome needs to be assembled 
intracellularly by heteromultimerization [17]. NLRP3 is seen as one of the major NLRs 
that activate the inflammasome, followed by the cleavage of pro-caspase-1. In our hands, 
using caspase-1 deficient mice, caspase-1 seems to be the major enzyme to cleave 
pro-IL-1β. However, at later time points after Borrelia exposure, caspase-1 might play a 
different role. Liu et al., [32] showed that caspase-1 knockout mice display higher arthritis 
scores at day 14 post infection. On day 45, the arthritis scores in these mice are lower 
as compared to wild-type mice. However, the inoculation method between this study and 
our data differs and might cause a different amount of spirochetes in the joint at early 
time points. Next to this, recently it was demonstrated that the caspase-1 knockout mice 
used in these studies were in fact double knock-out, they also lack functional caspase-11 
[33]. Recently, it was demonstrated that mice deficient for only caspase-1 were more 
susceptible for intracellular infections [34]. The caspase-1/11 deficient mice were less 
susceptible, indicating that caspase-11 may dampen the effect of caspase-1 in our 
findings. Taken this together, caspase-1 plays an important role in the induction of an 
inflammatory response against Borrelia spirochetes in the joint, but is less important in 
controlling spirochete burden at later time points.
Here we show that in vitro activation of caspase-1 in BMDMs after B.burgdorferi exposure, 
as well as production of IL-1β protein and bioactive IL-1β, is indeed NLRP3-dependent 
(Fig.4). However, intraarticular injection of B.burgdorferi did not differ between NLRP3 
knockout and wild-type mice in terms of joint inflammation and cytokine production. These 
results support recent reports showing that NLRP3 is not involved in other murine models 
of arthritis, such as antigen-induced arthritis, collagen-induced arthritis,  or gouty arthritis 
[35-37]. We cannot fully explain the difference in NLRP3 dependency between the in vitro 
and in vivo induction of IL-1β by B.burgdorferi. Explanations may be sought in in vivo 
activation of additional inflammasomes, or triggering of ASC-caspase-1 independently of 
NLRs [38-40], but this remains to be demonstrated.
Interestingly, ASC was found to be pivotal in the induction of Lyme arthritis. It is known 
that ASC is not just an adaptor protein within the inflammasome, but also has a role in 
antigen presentation and lymphocyte migration. It addition, it has been demonstrated that 
ASC controls mRNA stability and expression of Dock2, which is involved in Rac activation 
in immune cells [41]. Finally, ASC has been associated with NFкB signaling [42], which is 
the major pathway in the production of several cytokines.  
In contrast to TLR2-MyD88, neither NOD1 nor NOD2 were involved in the B.burgdorferi-
triggered caspase-1 activation and bioactive IL-1β production in BMDMs (Fig.2B/C). 
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However, in vivo we note a NOD1/NOD2/RICK-dependent cytokine production in synovial 
explants from mice with Lyme arthritis (Fig.6). The latter findings are in line with a recent 
report [3] in humans lacking functional NOD2, which show that Borrelia-induced IL-1β 
production is partly NOD2 dependent. Apparently the recognition of B.burgdorferi by 
murine or human immune cells through PRRs differs. Although earlier results demonstrate 
a specific role for RICK and NOD2 in the recognition and induction of Borrelia-dependent 
IL-1β production by human cells, we were unable to detect the important role for NOD2 in 
vivo for cell influx in murine Lyme arthritis [3]. However, the role of these PRRs in the in 
vitro cytokine induction using murine cells could be confirmed in the present study. 
An inhibitory role for NOD1 could be demonstrated in this manuscript, but was not found 
when studying human cytokine responses upon Borrelia stimulation. These discrepant 
observations might certainly be explained by differences between host species, it is 
described that humans express different PRR and explore different methods to induce 
a proper immune response against pathogens. Murine cells produce pro-inflammatory 
cytokines after B.burgdorferi exposure, such as IL-1β, KC, and TNF-α. Whether this 
difference is caused by hyperactive TLR2 signaling or lack of NOD2 mediated suppression 
is not elucidated yet.
The role of MyD88 in experimental Lyme disease, but also in the host response against 
B.burgdorferi was studied previously [43-45]. MyD88 deficient mice displayed severely 
higher amounts of spirochetes in several tissues, including the joints [11, 43]. It was 
shown that MyD88 knockout mice infected with live B.burgdorferi displayed more severe 
arthritis and cell influx as compared to infected wild-type mice [43]. Therefore, it was 
concluded in this study that Lyme arthritis occurs without the presence of the MyD88 
molecule. However, these findings can be explained by the fact that MyD88 deficient mice 
suffer from a higher spirochetal burden than wild-type mice. The excessive spirochetal 
load in the organs causes hyperinflammation that is MyD88-independent.
In the present study we detected an important role for MyD88 in the development of early 
murine Lyme arthritis. Mice deficient in this adaptor molecule were not able to develop 
arthritis after intra-articular injection of B.burgdorferi. TLR2 gene deficient mice were also 
unable to induce Lyme arthritis at early time points after injection of spirochetes. These 
data suggest that TLR2-MyD88 signaling is very important during the onset of Lyme 
arthritis.
The treatment of patients suffering from Lyme arthritis is a challenge for clinicians, as 
treatment is often ineffective. Patients suffering from gout, rheumatoid arthritis, or other 
inflammatory joint diseases benefit from treatment with the IL-1receptor antagonist 
(Anakinra) [46, 47]. Based on  present results indicating that IL-1 is one of the major 
mediators in Lyme arthritis, there is a rationale to propose that neutralizing IL-1 activity 
may also have beneficial effects in chronic Lyme arthritis. Apart from IL-1Ra, anti-IL-
1β antibodies like Canakinumab might be useful for treatment of Lyme disease since 
these antibodies express a long half-life in humans. Thus, understanding the precise 
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pathogenesis of Lyme disease may reveal novel therapeutic modalities in the near future. 
Conclusions 
In the present study, we have demonstrated that murine Lyme arthritis is strongly 
dependent on IL-1 production. Next to that, murine Lyme arthritis is ASC and caspase-1-
dependent, but NLRP3, NOD1, NOD2, and RICK independent. Caspase-1 activation by 
B. burgdorferi is dependent on TLR2 and MyD88.
In light of these findings, we propose a critical role for TLR2-MyD88-NLR-ASC-caspase-1 
cascade mediated IL-1β production in the pathogenesis of Lyme arthritis. The treatment 
of patients suffering from Lyme arthritis is still challenging for clinicians, and treatment 
for patients with chronic Lyme disease is often ineffective. Based on the present results 
indicating that IL-1 is one of the major mediators in Lyme arthritis, it is rationale to propose 
that neutralizing IL-1 activity may also have beneficial effects in chronic Lyme arthritis.
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Figure S1. IL-1β mRNA 
expression is TLR2 and MyD88 
dependent. (A) IL-1β mRNA 
expression levels (x1000) in bone 
marrow derived macrophages 
isolated from wild-type, TLR2-, 
MyD88-, NOD1-, NOD2-, and 
RICK-gene deficient mice. mRNA 
expression after 24 hours of 
stimulation with either medium or 
5x10^6 B.burgdorferi per mL. At 
least 5 animals per group, bars 
represent mean±SEM. *p<0.05; 
Mann–Whitney U test, two-tailed. 
IL-6 (B) and TNF-α (C) mRNA 
expression and protein production 
(in ng/mL for IL-6, and pg/mL for 
TNF-α, respectively) by bone 
marrow derived macrophages 
isolated from wild-type, TLR2-, 
MyD88-, NOD1-, NOD2-, and 
RICK-gene deficient mice. mRNA 
expression after 24 hours of 
stimulation with either medium or 
5x10^6 B.burgdorferi per mL. At 
least 5 animals per group, bars 
represent mean±SEM.
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Figure S2. Inflammasome-
independent IL-1β transcription. 
(A) IL-1β mRNA expression levels
(x1000) in bone marrow derived
macrophages isolated from
wild-type, NLRP3-, ASC-, and
caspase-1-gene deficient mice.
mRNA expression after 24 hours
of stimulation with either medium
or 5x10^6 B.burgdorferi per mL.
At least 5 animals per group,
bars represent mean±SEM.
IL-6 (B) and TNF-α (C) mRNA 
expression and protein production 
(in ng/mL for IL-6, and pg/mL for
TNF-α, respectively) by bone
marrow derived macrophages
isolated from wild-type, NLRP3-,
ASC-, and caspase-1-gene
deficient mice. mRNA expression
after 24 hours of stimulation
with either medium or 5x10^6
B.burgdorferi per mL. At least 5
animals per group, bars represent 
mean±SEM.
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Summary
Borrelia burgdorferi sensu lato is the causative agent of Lyme disease (LD). Recent studies 
have shown that recognition of the spirochete is mediated by TLR2 and NOD2. The latter 
receptor has been associated with the induction of the intracellular degradation process 
called autophagy. The present study demonstrated for the first time the induction of 
autophagy by exposure to B. burgdorferi and that autophagy modulates the B. burgdorferi-
dependent cytokine production. Human PBMCs treated with autophagy inhibitors showed 
an increased IL-1β and IL-6 production in response to the exposure of the spirochete, 
while TNFα production was unchanged. Autophagy induction against B. burgdorferi 
was dependent on reactive oxygen species (ROS) since cells from patients with chronic 
granulomatous disease (CGD), which are defective in ROS production, also produced 
elevated IL-1β. Further, the enhanced production of the pro-inflammatory cytokines was 
because of the elevated mRNA expression in the absence of autophagy. Our results thus 
demonstrate the induction of autophagy, which in-turn modulates cytokine production, by 
B. burgdorferi for the first time.
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Introduction
Lyme disease, the most common vector-borne disease in the US and Western Europe, 
is caused by bacteria of the species Borrelia burgdorferi sensu lato (1). Localized 
infection is typically manifested by an erythema migrans skin lesion. Depending on the 
subspecies, disseminated disease is mainly associated with arthritis (B. burgdorferi), skin 
disorders (B. afzelii), or neurological alterations (B. garinii) (2). Despite great advances 
in our understanding of the immunologic pathways triggered by the LD spirochete in 
humans (3-5), much remains to be learned regarding the immunopathogenesis of the 
disease. Several in vitro studies indicate the importance of lipid-modified proteins in the 
pathogenesis of the infection (6-8). The immune system recognizes these lipoproteins by 
different pattern recognition receptors (PRRs), of which Toll-like receptor 2 (TLR2) and 
Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) are suggested to 
be the most important (4,9). The activation of PRRs after recognition of Borrelia results 
in the secretion of the pro-inflammatory cytokine IL-1β which is known to be involved in 
the pathogenesis of Lyme disease (10-12). IL-1β production requires two important steps: 
transcription of mRNA resulting in the production of proIL-1β protein, and cleavage of the 
immature precursor into mature bioactive IL-1β by the inflammasome-enzyme caspase-1 
(13).
In addition to the induction of intracellular signals leading to the production of cytokines, 
engagement of PRRs such as NOD2 activates autophagy, a process in which 
damaged organelles or long-lived proteins are degraded (14-17). Autophagy involves 
the sequestration of dysfunctional proteins in a double-layered membrane called 
autophagosome, which is formed by the elongation of small membrane structures. The 
formation of this isolation membrane is initiated by autophagy-related gene (Atg) 16 and 
type III phosphatidylinositol 3-kinase (PI3K)(18). The delivery of dysfunctional proteins to 
the autophagosomes is regulated by autophagic adaptors such as p62. This latter protein 
can bind to the intracellular target as well as to the microtubule-associated protein 1 light 
chain 3 (LC3), which associates with the autophagosome after being processed (19). 
Autophagosomes mature through fusion with lysosomes, leading to the breakdown of the 
protein content (20). 
The link between autophagy and the innate defense mechanism has been made 
in several studies describing the connection between dysfunctional autophagy and 
autoinflammatory diseases (21-24). It has been shown that the inhibition of autophagy 
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by chemical inhibitors of PI3 kinases leads to an enhancement of extracellular IL-1β after 
stimulation with bacterial wall components such as LPS (25). This observation, next to the 
fact that B. burgdorferi is thought to be recognized by the autophagy-inducing receptor 
NOD2, prompted us to investigate the role of autophagy in host defense during infection 
with B. burgdorferi. By stimulating human peripheral blood mononuclear cells (PBMCs), 
we demonstrate that inhibition of autophagy increases IL-1β and IL-6 production after 
stimulation with Borrelia bacteria. The enhanced production was specific for IL-1β and 
IL-6, while TNFα production was unchanged. The robust increase in mRNA synthesis of 
the proinflammatory cytokines IL-1β and IL-6 indicated that autophagy regulates Borrelia-
induced IL-1β production at the transcriptional level.
Experimental Procedures
Borrelia burgdorferi cultures. B. burgdorferi, ATCC strain 35210, was cultured at 33°C 
in Barbour-Stoenner-Kelley (BSK)-H medium (Sigma-Aldrich) supplemented with 6% 
rabbit serum. Spirochetes were grown to late-logarithmic phase and examined for motility 
by dark-field microscopy. Organisms were quantitated by fluorescence microscopy 
after mixing 10 µL aliquots of culture material with 10 µL of an acridine orange solution 
and counted using a Petroff-Hauser counting chamber. Bacteria were harvested by 
centrifugation of the culture at 7000 x g for 15 min., washed twice with sterile PBS (pH 
7.4), and diluted in the specified medium to required concentrations.
Isolation of human peripheral blood mononuclear cells and in vitro cytokine 
production. Venous blood was drawn from the cubital vein of healthy volunteers or 
patients with CGD into 10 ml EDTA tubes (Monoject, Covidien, Mansfield, Massachusetts, 
USA). The mononuclear cell fraction was obtained by density centrifugation of blood 
diluted 1:1 in pyrogen-free saline over Ficoll-Paque (Pharmacia Biotech, Pittsburgh, 
Pennsylvania, USA). Cells were washed twice in saline and suspended in culture medium 
(RPMI; Invitrogen, Carlsbad, California, USA) supplemented with gentamicin 10 mg/ml, 
L-glutamine 10 mM and pyruvate 10 mM. Cells were counted in a Coulter counter (Coulter 
Electronics, Brea, California, USA) and the number was adjusted to 5x106 cells/ ml. A 
total of 5x105 mononuclear cells in a 100 ml volume was added to round-bottom 96-well 
plates (Greiner, Monroe, North Carolina, USA) and incubated with either 100 ml of culture 
medium (negative control), or B. burgdorferi (MOI 0.2). In some experiments, PBMCs 
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were pre-incubated with culture medium or the autophagy inhibitors 3-methyl adenine 
(3-MA, 10 mM; Sigma), Wortmannin (10 µg/mL, BioLegend) or LY294002 (100μM, 
Invivogen) for 60 minutes. After 24 hours, supernatants were collected and stored at 
−20°C until being assayed.
Real-time PCR. RNA from PBMCs was isolated using TRIzol reagent (Invitrogen) following 
the manufacturer’s instructions. Isolated RNA was reversed transcribed into complementary 
DNA using iScript cDNA synthesis kit (Bio-Rad Laboratories BV, Veenendaal, the 
Netherlands). Quantitative real-time PCR was performed using Power SYBR Green 
PCR Master Mix (Applied Biosystems) using a 7300 Real-time PCR system (Applied 
Biosystems). In each PCR reaction a melting curve analysis was included to control for 
aspecific PCR amplification. Primers used for the experiments (final concentration 10μM) 
are shown below. Real-time qPCR data were corrected for expression of the housekeeping 
gene human GAPDH. Human IL-1β; Forward sequence 5’-3’: GCC-CTA-AAC-AGA-TGA-
AGT-GCT-C, Reversed sequence 5’-3’: GAA-CCA-GCA-TCT-TCC-TCA-G, Human IL-6; 
Forward sequence 5’-3’: AAT-TCG-GTA-CAT-CCT-CGA-CGG, Reversed sequence 5’-3’: 
GGT-TGT-TTT-CTG-CCA-GTG-CCT, Human TNFα; Forward sequence 5’-3’: TGG-CCC-
AGG-CAG-TCA-GA, Reversed sequence 5’-3’: GGT-TTG-CTA-CAA-CAT-GGG-CTA-CA, 
Human GAPDH; Forward sequence 5’-3’: AGG-GGA-GAT-TCA-GTG-TGG-TG, Reversed 
sequence 5’-3’: CGA-CCA-CTT-TGT-CAA-GCT-CA. Cycling conditions were 2 min at 
50°C and 10 min at 95°C followed by 40 cycli of 95°C for 15 sec and 1 min at 60°C.
Cytokine measurements. Concentrations of human IL-1β, pro-IL-1β IL-6, TNFα, or 
IL-1RA were determined in duplicates using specific commercial ELISA kits (Sanquin, 
Amsterdam, or R&D Systems, Minneapolis), in accordance with the manufacturers‘ 
instructions. Levels of bioactive IL-1 were measured using a murine thyoma cell line EL4/
NOB1 that produces IL-2 in response to active IL-1 as described above.
Western blot. For Western blotting of LC3 and GAPDH, cells were washed and samples 
prepared for SDS-PAGE by lysing the cells in RIPA buffer. After protein electrophoresis 
in a 15% polyacrylamide gel, proteins were transferred to a nitrocellulose membrane by 
western blotting. The membrane was first incubated with rabbit primary antibody specific 
for LC3-II or GAPDH, followed by a secondary goat-anti-rabbit antibody conjugated to 
horseradish peroxidase. Enhance chemiluminescence was used to detect the proteins. 
For Western blotting of caspase-1 and actin, cells were washed twice with sterile PBS 
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and lysed in buffer (150 mM NaCl, 10 mM Tris, pH 7.4, 5 mM EDTA, 1 mM EGTA, 0.1% 
Nonidet P-40) supplemented with a Roche protease inhibitor cocktail tablet. Proteins were 
separated using SDS-PAGE (12% polyacrylamide gel) and subsequently transferred to 
a PVDF membrane. The membranes were coated with primary antibodies and active 
caspase-1 or actin were detected using secondary anti-rabbit antibody conjugated to 
horseradish peroxidase followed by enhanced chemiluminescence.
Fluorescence Microscopy. HeLa cells were transfected with a plasmid containing GFP-
LC3 (kindly provided by Dr. T Yoshimori, Osaka, Japan) using the transfection medium 
Fugene 6 (Roche) according to the manufacturer’s instructions. GFP-LC3+ HeLa cells 
were grown and stimulated on coverslips (19-mm diameter) in 12-well plates. Cells were 
fixed with 2% paraformaldehyde for 15 min at room temperature and permeabilized for 10 
min with cold methanol (100%). After washing with PBS (×3), the coverslips were mounted 
onto glass slides with Vectashild +DAPI and analyzed on a fluorescence microscope.
Confocal microscopy. HeLa cells were grown and stimulated on coverslips (19-mm 
diameter) in 12-well plates. Cells were fixed with 2% paraformaldehyde for 15 min at 
room temperature. After washing with PBS, cells were stained with anti HLA class I Alexa 
Fluor 649 + DAPI and analyzed on a confocal microscope. 
ROS measurement. PBMCs were suspended in HBSS (Hank’s Buffered Salt 
Solution) and exposed to different concentrations of B. burgdorferi. ROS formation was 
measured by a chemiluminescence assay using luminol (5mM, 5-amino-2,3-dihydro-
1,4-phthalazinedione, Sigma). The luminometer measured chemiluminescence in the 
integration mode at 37°C for 1 hour after luminol had been added. 
Ethics statement. All human experiments were conducted according to the principles 
expressed in the Declaration of Helsinki. Before taking blood, informed written consent 
of each human subject was provided. The study was approved by the review board of 
Radboud University Nijmegen Medical Centre.
Statistical Analysis. Data are expressed as mean ± SEM unless otherwise indicated. 
Differences between experimental groups were tested using the two-sided Mann-Whitney 
U test performed on GraphPad Prism 4.0 software (GraphPad). P values of ≤0.05 were 
considered significant.
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Results
B. burgdorferi induces autophagy. Previous studies demonstrated that autophagy 
inhibits LPS-induced IL-1β in human PBMCs (25). Since IL-1β is associated with the 
pathogenesis of Lyme disease (12), we assessed the role of autophagy during the exposure 
to B. burgdorferi based on microtubule associated protein 1 light chain 3 (LC3). During 
autophagy, the cytoplasmic form (LC3-I) is processed into the phosphatidylethanolamine-
conjugated form (LC3-II), the latter indicating activation of autophagy inside the cells. 
GFP-LC3 expressing HeLa cells were exposed to B. burgdorferi alone or in combination 
with the autophagy inhibitors 3-Methyl Adenine (3MA) or Wortmannin (Figure 1A). An 
increase in autophagosome formation can be seen after exposure to B. burgdorferi 
demonstrated by a high number of GFP-LC3+ punctae. 3MA and Wortmannin inhibited 
the formation of those vesicles attesting the validity of this model. Previously, it has been 
demonstrated that primary cells as PBMCs but not all cell lines are able to phagocytose 
the spirochetes (26). Therefore, the ability of the used model (HeLa cells) to internalize 
B. burgdorferi has been investigated. Internalized spirochetes can be seen indicating the 
legality of the model (Figure 1B). Western blot analysis of LC3 in murine BMDMs showed 
an increased amount of LC3-II after exposure to B. burgdorferi (Figure 1C). 
Inhibition of autophagy enhances IL-1β and IL-6 production but not TNFα. To 
determine the role of autophagy in the induction of proinflammatory cytokines by B. 
burgdorferi, PBMCs obtained from healthy volunteers were stimulated for 24h with the 
spirochete alone or in combination with different autophagy inhibitors. 3MA blocks the 
activity of PI3-kinases, which are mandatory for the initiation of autophagy. PBMCs 
treated with autophagy inhibitors showed significantly higher IL-1β and IL-6 production 
after exposure to B. burgdorferi (Figure 2A/B). To corroborate the findings of 3MA,  other 
inhibitors were used (Wortmannin, LY294002). In contrast, no increase in TNFα production 
could be observed by blocking autophagy with 3MA, Wortmannin or LY294003 (Figure 
2C). In line with the results of the secreted IL-1β protein, intracellular concentrations of 
total IL-1β were also enhanced (Figure 2G). To examine whether inhibition of autophagy 
during exposure to Borrelia results in altered mRNA levels, we measured transcription of 
several cytokines. IL-1β and IL-6 mRNA levels were strongly increased in human PBMCs 
after Borrelia recognition when autophagy was inhibited (Figure 2D+E). In contrast, 
the level of TNFα mRNA was not influenced (Figure 2F). To exclude any alteration of 
cytokine production due to the autophagy inhibitors alone, we blocked autophagy in 
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non-stimulated PBMCs, and no increase of cytokine production was observed (data not 
shown). Using murine ATG7 deficient bone marrow derived macrophages (BMDM), an 
enhanced production of IL-1β could be seen after the exposure to B. burgdorferi (data 
not shown). These finding underscore our results that inhibition of autophagy leads to 
enhanced IL-1β production after Borrelia exposure.
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FIGURE 1: Activation of autophagy by Borrelia burgdorferi. (A) GFP-LC3-expressing HeLa cells were pre-
incubated for 1 hour at 37°C in RPMI alone, containing 3MA (10mM) or Wortmannin (100nM) in which inhibitors of 
lysosomal fusion such as Ammonium chloride (20mM) and Leupeptine (100mM) have been added. After 2 hours 
of stimulation with culture medium or B. burgdorferi (MOI 0.4), cells were fixed, nuclei stained with DAPI (blue) and 
slides were analyzed by fluorescence microscopy. Data are representative of at least four experiments. (B) HeLa 
cells were exposed to GFP- labeled B. burgdorferi (MOI 1) for 2 hours, cells were fixed, membrane stained with anti 
HLA class I Alexa Fluor 649 (red) and nuclei stained with DAPI (blue). Slides were analyzed by confocal microscopy. 
Data are representative of at least four experiments (C) Western Blot analysis of LC3-II in lysates of mouse BMDMs 
stimulated with B. burgdorferi (MOI 5) for indicated periods of time.
53
Increased extracellular IL-1β is not based on the secretion of immature IL-1β 
protein. To exclude the possibility of an increased secretion of immature (and inactive) 
IL-1β by autophagy inhibitors, the bioactivity of extracellular IL-1β was measured using a 
murine thyoma cell line EL4/NOB1, which produces IL-2 in response to active IL-1. The 
amount of bioactive IL-1 increased in the presence of autophagy inhibitors (Figure 3A). 
To support these data, the amount of pro-IL-1β was measured in the supernatants of 
PBMCs incubated with B. burgdorferi alone or in combination with autophagy inhibitors. 
No difference in the amount of proIL-1β could be found in the supernatant of the various 
samples (Figure 3B). An increase in proinflammatory cytokines due to cell death was also 
excluded, since the level of LDH, a marker for cell death, stayed below the detection level 
in all  samples (data not shown).  
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FIGURE 2: Modulation of B. burgdorferi-induced inflammatory cytokine 
production by the inhibition of autophagy. Freshly isolated human PBMCs 
were preincubated for 1 hour at 37°C in culture medium in the presence or 
absence of autophagy inhibitors such as 3MA (10mM), Wortmannin (100nM), 
LY294002 (100μM) and afterwards stimulated with B. burgdorferi (MOI 0.2) 
for 24 hours. IL-1β (A), IL-6 (B) and TNFα (C) in the supernatants as well 
as intracellular IL-1β (G) in cell lysates were measured by specific ELISA. 
IL-1β (D), IL-6 (E) and TNFα (F) expression levels have been determined by 
RT-PCR. Bars represent mean±SEM of cells harvested from 8 volunteers; 
*p<0.05; **p<0.01; ***p<0.0001, Mann-Whitney U-test, two-sided.
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Inhibition of autophagy does not increase caspase-1 activity. IL-1β is synthesized 
as an immature pro-form (pro-IL-1β) which requires activated caspase-1, a component of 
the inflammasome, for cleavage into mature IL-1β secreted from the cells. To determine 
the role of autophagy in the activation of caspase-1 leading to processing of immature IL-
1β, PBMCs obtained from healthy volunteers were stimulated with B. burgdorferi alone or 
in combination with several autophagy inhibitors for 3h. The amount of active caspase-1 
stayed the same independent of the inhibition of autophagy (Figure 4). Furthermore, the 
influence of caspase-1 on the induction of autophagy by B. burgdorferi has been analyzed 
using GFP-LC3 expressing HeLa cells incubated with the caspase-1 inhibitor YVAD and 
Borrelia. No effect on autophagosome formation by caspase-1 inhibition was seen after 
exposure of the GFP-LC3 cells to B. burgdorferi (data not shown).
B. burgdorferi-induced reactive oxygen species (ROS) reduce the production of IL-
1β. It has been proposed that the formation of reactive oxygen species forms a necessary 
step in the induction of autophagy (27,28). We therefore hypothesized that defects in 
the production of ROS would result in a defective autophagic process, followed by an 
increase in IL-1β production. The exposure of B. burgdorferi to PBMCs resulted in a 
significant increase in ROS compared to unstimulated samples (Figure 5A). To further 
assess the production of cytokines in response to ROS, PBMCs of patients with chronic 
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FIGURE 3: Bioactivity of extracellular IL-1β. Freshly isolated human PBMCs were preincubated for 1 hour at 37°C 
in culture medium in the presence or absence of autophagy inhibitors such as 3MA (10mM), Wortmannin (100nM), 
LY294002 (100μM) and afterwards stimulated with B. burgdorferi (MOI 0.2) for 24 hours. (A) Supernatant was added 
to murine NOB-1 cells which react to functional human IL-1 with the secretion of IL-2. Murine IL-2 was measured in 
the supernatant of NOB-1 cells after 24h. (B) Pro-IL-1β was measured in supernatants using a specific ELISA. Data 
from 4 volunteers are shown as mean±SEM; *p<0.05; **p<0.01, Mann-Whitney U-test, two-sided.
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granulomatous disease (CGD), who have a defective production of reactive oxygen 
species, were exposed to B. burgdorferi for 24h (Figure 5B). Cells of CGD patients 
showed higher production of IL-1β compared to healthy controls, supporting our previous 
data of increased B. burgdorferi-induced cytokines during impaired autophagy (Figure 
2A).
Enhanced production of IL-1β and IL-6 during inhibition of autophagy is not based 
on IL-1β feedback-loop. Previous studies showed that exogenous IL-1β induces 
endogenous IL-1β and IL-6 mRNA expression and protein production. To assess the 
influence of extracellular bioactive IL-1β on the production of cytokines by PBMCs, which 
have been treated with autophagy inhibitors, we blocked the IL-1 receptor using IL-1ra 
(Anakinra) and analyzed the production of cytokines at mRNA level as well as secreted 
protein. PBMCs treated with IL-1ra in combination with 3MA or Wortmannin produce a 
larger amount of IL-1β and IL-6 in response to B. burgdorferi at both mRNA expression 
and protein levels (Figure 6 A, B, D, E, G). In contrast, TNFα mRNA expression, as well as 
the secreted TNFα protein, was not affected by autophagy inhibitors even in the presence 
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FIGURE 4: Autophagy does not influence the activation of caspase-1. Western Blot analysis of caspase-1 in 
lysates of autophagy-impaired human PBMCs stimulated with B. burgdorferi (MOI 2). PBMCs were pre-incubated 
for 1 hour at 37°C in RPMI alone, containing 3MA (10mM) or Wortmannin (100nM). After 3 hours of stimulation with 
culture medium or B. burgdorferi, cells have been lysed and were further analyzed with Western Blot. The picture is 
representative for results obtained from 4 volunteers.
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of IL-1ra (Figure 6C, F).
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FIGURE 5: Production of IL-1β after B. burgdorferi stimulation is controlled by Reactive Oxygen Species. 
(A) Freshly isolated human PBMCs were stimulated with B. burgdorferi for one hour. The production of ROS was
measured by chemiluminescence using luminol. (B) Freshly isolated human PBMCs of healthy volunteers and CGD
patients were stimulated with B. burgdorferi for 24 hours. IL-1β was measured in the supernatant by specific ELISA.
Bars represent mean±SEM; *p<0.05, Mann-Whitney U-test, two-sided. N=4 controls, patients.
FIGURE 6: Effect of IL-1ra on the autophagy-related increase in 
inflammatory cytokine production. Human PBMCs were preincubated 
for 1 hour at 37°C in culture medium in the presence or absence of IL-
1ra and autophagy inhibitors such as 3MA (10mM), Wortmannin (100nM), 
LY294002 (100μM). Afterwards, cells were stimulated with B. burgdorferi 
(MOI 0.2) for 24 hours. IL-1β (A), IL-6 (B) and TNFα (C) in the supernatants 
as well as intracellular IL-1β (G) in cell lysates were measured by specific 
ELISA. IL-1β (D), IL-6 (E) and TNFα (F) expression levels have been 
determined by RT-PCR. Bars represent mean±SEM of data obtained in 6 
volunteers; *p<0.05, Mann-Whitney U-test, two-sided.
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Discussion
The link between autophagy and innate immunity, and its role as a defense mechanism 
against invading pathogens has been made in several studies (29-31), suggesting a 
regulatory role of autophagy on inflammasome activation and production of cytokines upon 
stimulation with microbial ligands (32). Since IL-1β has been demonstrated to contribute 
to the pathogenesis of Lyme disease (12), we examined the role of autophagy for the 
production of this pivotal proinflammatory cytokine in response to B. burgdorferi. Although 
both mRNA expression and production of TNFα was not enhanced in autophagy-blocked 
PBMCs stimulated with the Borrelia-spirochete, secretion of IL-1β and IL-6 protein was 
highly elevated. In addition, the mRNA synthesis of IL-1 β and IL-6 was strongly increased 
as well, indicating that the inhibition of autophagy modulates IL-1β and IL-6 production at 
the transcriptional level.
IL-1β is synthesized as an inactive pro-cytokine (pro-IL-1β) and requires activated 
caspase-1, a component of the inflammasomes, for cleavage into mature bioactive IL-1β. 
Since recent studies revealed an association between genetic disorders involving the 
activation of the inflammasome and autoinflammatory disorders (33-35), we investigated 
the effect of autophagy on the activation of inflammasome/caspase-1. In contrast to 
murine studies (36), autophagy did not inhibit inflammasome activation in human PBMCs, 
supporting our previous studies that demonstrated that autophagy inhibition affected 
the transcription, rather than processing, of IL-1β. The constitutive active caspase-1 in 
primary human monocytes, in contrast to the inactive caspase-1 of mouse macrophages, 
may explain the different results (37). An increased release of pro-IL-1β secretion due to 
cell death could be excluded by evaluation of the bioactivity of IL1 that was significantly 
increased by autophagy inhibitors (Fig 3). 
The increased production of IL-6 after inhibition of autophagy is most probably a 
consequence of increased bioactive IL-1β, since it has been shown that IL-1receptor 
signaling is a major inducer of IL-6 (38). Interestingly, production of TNFα was not 
affected, which can be explained by different induction pathways. It has been shown 
that p38-MAPK and NF-κB are main inducers of TNFα transcription, whereas additional 
pathways such as extracellular signal-related kinase/nuclear factor kappa B (Erk/NF-κB) 
are needed for the transcription of IL-1β (39,40). 
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Recent studies have revealed that formation of reactive oxygen species (ROS) forms a 
necessary step in the initiation of autophagy (27,28). Several TLRs are able to activate 
Nox2 leading to the generation of ROS. These oxidative conditions are essential for 
autophagy induction, as treatment with anti-oxidative agents abolishes the formation 
of autophagosomes (27).  We therefore hypothesized that defects in the production of 
ROS would result in a defective autophagic process, followed by an increase in IL-1β 
production. Consistent with this hypothesis, cells isolated from patients with CGD, who 
have a defective production of ROS due to genetic defects in the genes forming the 
NADPH complex, had an enhanced production of IL-1β compared to healthy controls (Fig 
5). These additional data support our results of increased production of B. burgdorferi-
induced cytokines in autophagy-impaired cells (Figure 2A/B).
Extracellular IL-1β performs its pro-inflammatory effect via an autocrine mechanism 
followed by binding to its cognate receptor IL1 receptor type I (41). In the present study, we 
used recombinant IL-1 receptor antagonist (IL-1ra) to determine the contribution of an IL-
1-positive feedback loop to the total amount of B. burgdorferi-induced cytokine production. 
IL-1R blockade in autophagy capable cells resulted in reduced cytokine concentrations 
after Borrelia exposure. However, in cells in which autophagy was impaired, we noted an 
increased induction of cytokines by B. burgdorferi even if IL-1ra was added to the medium 
to block the IL1-induced loop, suggesting an IL-1R independent mechanism.
In previous reports it was described that autophagy plays a role in the cytokine response 
to several TLR-ligands (32,42). However, this is the first study to show an influence 
of autophagy on the Borrelia-induced cytokine response. The precise mechanism 
underlying the effect of autophagy on IL-1β production induced by B. burgdorferi remains 
to be elucidated in further detail. Lee et al. (43) proposed a model in which autophagy 
suppresses the IL-1β signaling by downregulating p62 levels (25,43). P62 acts a selective 
autophagy receptor for ubiquitinated protein aggregates (44) and as an important scaffold 
in the IL-1β signaling pathway by promoting oligomerization and activation of TRAF6 
resulting in the transcription of NF-κB (45) and consequently increased IL-1β production. 
The expression level of p62 is important for these functions and it is thought to be 
regulated by autophagy. In the absence of this degradation process, increased p62 levels 
promote oligomerization and activation of TRAF6 resulting in overactivation of NF-κB. 
Therefore, we propose that the recognition of B. burgdorferi by TLR2 and NOD2 induces 
the production of IL-1β. In the absence of autophagy, p62 levels will be elevated, leading 
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to even more TRAF6 aggregation and consequently more IL-1β production.
The autophagy-dependent increase of IL-1β in PBMCs seems to be Borrelia-specific, 
since the exposure of different pathogens such as Candida albicans to autophagy-
impaired cells resulted in a decreased IL-1β response (data not shown).  Therefore, a 
better understanding of the precise mechanisms underlying the altered IL-1β production 
upon B. burgdorferi stimulation in autophagy-impaired cells may lead to the identification 
of novel therapeutic targets that may be important in the pathogenesis of Lyme disease 
in which IL1-dependent inflammation is central. 
It is tempting to speculate that inhibition of autophagy could be beneficial during the early 
phase of Lyme disease leading to higher concentrations of IL-1β and therefore a possibly 
improved clearance of the pathogen. However, since Lyme disease occurs in different 
stadia, enhanced IL-1β production by autophagy modulation in disseminated Lyme 
disease might be detrimental for the disease activity. Several studies indicated a link 
between a high concentrations of IL-1β and pathogenic Th17 cells l leading to increased 
joint damage in rheumatoid arthritis (RA) or psoriasis patients (46,47). Therefore, the 
induction of autophagy in the disseminated state of Lyme disease could be favorable for 
Lyme patients through a decreased IL-1β production and inhibition of pathogenic Th17 
cells. 
In summary, we have elucidated the link between B. burgdorferi recognition and an 
important regulatory mechanism of inflammation by autophagy in Lyme disease. These 
findings may reveal novel therapeutic targets to treat Lyme disease patients in the future. 
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Abstract
We have previously demonstrated that inhibition of autophagy increased the Borrelia 
burgdorferi induced innate cytokine production in vitro, but little is known regarding 
the effect of autophagy on in vivo models of Borrelia infection. Here we showed that 
ATG7 deficient mice that were intraarticular injected with Borrelia spirochetes displayed 
increased joint swelling, cell influx and enhanced IL-1β and IL-6 production by inflamed 
synovial tissue. Since both IL-1β and IL-6 are linked to the development of adaptive 
immune responses, we examine the function of autophagy on Borrelia induced adaptive 
immunity. Human peripheral blood mononuclear cells treated with autophagy inhibitors 
showed an increase in IL-17, IL-22 and IFN-γ production in response to exposure of B. 
burgdorferi. Increased IL-17 production was dependent on IL-1β release, but interestingly 
not on IL-23 production. In addition, cytokine QTLs in ATG9B modulate the Borrelia-
induced IL-17 production. Since high levels of IL-17 have been found in patients with 
confirmed severe chronic borreliosis, we propose that the modulation of autophagy 
may be a potential target for anti-inflammatory therapy in patients with persistent Lyme 
Disease.
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Introduction
Borrelia burgdorferi sensu lato, the causative agent of Lyme disease, stimulates a 
complex series of inflammatory events to eliminate the spirochete following infection [1]. 
The first most common sign of infection manifests as erythema migrans (EM) skin lesions, 
frequently accompanied by flu-like symptoms [2]. If treated correctly, the prognosis of these 
patients is excellent; however, if untreated, hematogenous dissemination of spirochetes 
may give rise to a wide range of clinical manifestations involving the central nervous 
system (mainly caused by B. garinii), the skin (B. afzelii) or the joints (B. burgdorferi) [3, 4]. 
Cytokines play a very important role in the pathogenesis of Lyme disease by regulating 
the immune responses against Borrelia. Several in vitro studies showed the important role 
of secreted IL-1β in response to Borrelia [5, 6]. High amounts of this cytokine were found 
near the location of erythema migrans lesions after tick bites [7]. IL-1 has a broad range 
of functions in mediating inflammation in protective immunity to infectious diseases, but 
it is also responsible for hyperinflammation in diseases associated with a dysregulated 
immune responses. IL-1β induces in synergy with IL-23 the production of IL-17 and related 
cytokines from Th17 cells [8], which have been associated to increased joint damage in 
rheumatoid arthritis or psoriasis patients [9, 10]. Next to that, IL-17 has been associated 
to the chronic stage of murine Lyme disease and inhibition of IL-17 by antibodies strongly 
reduced the development of Lyme arthritis shown by reduced joint swelling [11].
Previous studies have shown that autophagy, a highly conserved homeostatic mechanism 
that orchestrates the degradation of damaged cytosolic proteins, can modulate the IL-
1β response to pathogens including Borrelia spirochetes [12]. Furthermore, inhibition of 
autophagy promotes the secretion of IL-1β which leads to elevated IL-17 levels after LPS 
stimulation [13].
In this report we investigated the role of autophagy in a knock-out mouse model of Lyme 
arthritis by injecting B. burgdorferi into the knee joints of the animals. ATG7 knock-out mice 
showed an increase in joint swelling, elevated cell influx into the joint cavity as well as 
increased cytokine levels. In addition, we investigated the role of autophagy on Borrelia-
induced adaptive cytokines. The inhibition of autophagy by wortmannin increased the 
production of IL-17, IL-22 and IFN-γ in response to Borrelia bacteria. The increase of 
IL-17 was a specific response to elevated IL-1β levels and independent of elevated IL-23 
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levels. These findings underline the important role of autophagy in the pathogenesis of 
Lyme disease, and suggest that modulation of autophagy could be a novel therapeutic 
strategy in Lyme disease. 
Methods
B. burgdorferi cultures. B. burgdorferi, ATCC strain 35210, was cultured at 33°C in
Barbour-Stoenner-Kelley (BSK)-H medium (Sigma-Aldrich) supplemented with 6% rabbit
serum. Spirochetes were grown to late-logarithmic phase and examined for motility by dark-
field microscopy. Organisms were quantitated by fluorescence microscopy after mixing
10 µL aliquots of culture material with 10 µL of an acridine orange solution and counted
using a Petroff-Hauser counting chamber. Bacteria were harvested by centrifugation of
the culture at 7000 x g for 15 min., washed twice with sterile PBS (pH 7.4), and diluted in
the specified medium to required concentrations of 1×106 spirochetes per ml.
Animals. All mice were maintained at St. Jude Children’s Research Hospital (kindly 
provided by Douglas R. Green, St. Jude Children’s Research Hospital, Memphis, TN, 
USA) and were described before [14]. Mice were housed in a specific pathogen-free 
(SPF) facility, and experiments were conducted under protocols approved by the St. Jude 
Children’s Research Hospital’s Committee on the Use and Care of Animals.
Isolation of human peripheral blood mononuclear cells and in vitro cytokine 
production. Venous blood was drawn from the cubital vein of healthy volunteers into 10 ml 
EDTA tubes (Monoject, Covidien, Mansfield, Massachusetts, USA). The mononuclear cell 
fraction was obtained by density centrifugation of blood diluted 1:1 in pyrogen-free saline 
over Ficoll-Paque (Pharmacia Biotech, Pittsburgh, Pennsylvania, USA). Cells were washed 
twice in saline and suspended in culture medium (RPMI; Invitrogen, Carlsbad, California, 
USA) supplemented with gentamicin 50 mg/ml, L-glutamine 2 mM and pyruvate 1 mM. 
Cells were counted in a Coulter counter (Coulter Electronics, Brea, California, USA) and 
the number was adjusted to 5x106 cells/ ml. A total of 5x105 mononuclear cells in a 100 µl 
volume was added to round-bottom 96-well plates (Greiner, Monroe, North Carolina, USA) 
and incubated with either 100 µl of culture medium (negative control), or B. burgdorferi 
(106 spirochetes per ml). In some experiments, PBMCs were pre-incubated with culture 
medium or the autophagy inhibitor wortmannin (100nM) for 60 minutes. At indicated time 
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points, supernatants were collected and stored at −20°C until being assayed.
CD4, CD8, CD56 depletion. To deplete cells from isolated PBMCs, cell subpopulations 
were labeled using magnetic beads coated with anti-CD4, anti-CD8 or anti-CD56 (MACS; 
Miltenyi Biotec, Germany). Subsequently, cells were depleted over a depletion column 
according to the protocol supplied by the manufacturer. As control for the isolation procedure, 
non-depleted PBMCs were also washed over the columns without coated beads.
Cytokine measurements. Concentrations of human IL-1α, IL-1β, IL-1ra, IL-23, TNFα, 
IL-17A, IL17F, IL-22, or IFNγ were determined in duplicates using specific commercial 
ELISA kits (Sanquin, Amsterdam, or R&D Systems, Minneapolis), in accordance with the 
manufacturers’ instructions.
Real-time PCR. RNA from PBMCs was isolated using TRIzol reagent (Invitrogen) following 
the manufacturer’s instructions. Isolated RNA was reversed transcribed into complementary 
DNA using iScript cDNA synthesis kit (Bio-Rad Laboratories BV, Veenendaal, the 
Netherlands). Quantitative real-time PCR was performed using Power SYBR Green PCR 
Master Mix (Applied Biosystems) using a 7300 Real-time PCR system (Applied Biosystems). 
In each PCR reaction a melting curve analysis was included to control for aspecific PCR 
amplification. Primers used for the experiments (final concentration 10μM) are shown below. 
Real-time qPCR data were corrected for expression of the housekeeping gene human B2M. 
Human IL-1β; Forward sequence 5’-3’: GCC-CTA-AAC-AGA-TGA-AGT-GCT-C, Reversed 
sequence 5’-3’: GAA-CCA-GCA-TCT-TCC-TCA-G, Human IL-23; Forward sequence 5’-
3’: CAG-CTT-CAT-GCC-TCC-CTA-CT, Reversed sequence 5’-3’: GAC-TGA-GGC-TTG-
GAA-TCT-GC, Human TNF-α; Forward sequence 5’-3’: TGG-CCC-AGG-CAG-TCA-GA, 
Reversed sequence 5’-3’: GGT-TTG-CTA-CAA-CAT-GGG-CTA-CA, Human B2M; Forward 
sequence 5’-3’: ATG-AGT-ATG-CCT-GCC-GTG-TG, Reversed sequence 5’-3’: CCA-AAT-
GCG-GCA-TCT-TCA-AAC, human IL-17A; Forward sequence 5’-3’: CAA-TCC-CAA-AAG-
GTC-CTC-AG, Reversed sequence 5’-3’: CAC-TTT-GCC-TCC-CAG-ATC-A, human IL-17F; 
Forward sequence 5’-3’: GGC-ATC-ATC-AAT-GAA-AAC-CA, Reversed sequence 5’-3’: 
CTG-TAC-AAC-TTC-CGA-GGG-GTA, human IL-22; Forward sequence 5’-3’: CAG-CAG-
CCC-TAT-ATC-ACC-AA, Reversed sequence 5’-3’: GGA-ACA-GTT-TCT-CCC-CAA-TG, 
human IFN-γ; Forward sequence 5’-3’: CGA-GAT-GAC-TTC-GAA-AAG-CTG, Reversed 
sequence 5’-3’: CAG-TTC-AGC-CAT-CAC-TTG-GA. Cycling conditions were 2 min at 50°C 
and 10 min at 95°C followed by 40 cycli of 95°C for 15 sec and 1 min at 60°C.
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Intracellular IL-17, IL-22 and IFN-γ flow cytometry. Following 7 days stimulation, PBMCs 
were stimulated for 4-6 hours with PMA (50ng/ml) (Sigma-Aldrich), ionomycin (1µg/ml) 
(Sigma-Aldrich) and GolgiPlug (BD Biosciences) according to the protocols supplied by 
the manufacturers. Cells were stained extracellular using APC-CD4, FITC-CD4, PE-CD56, 
PECy7-CD56, ECD-CD8, PE-Cy7-CD45 or APC-CD45 antibodies (BD Biosciences or 
Beckman Coulter). Subsequently, cells were fixed and permeabilized with Cytofix/Cytoperm 
solution (eBioscience) according to the protocols supplied by the manufacturer. Following 
permeabilization, cells were stained intracellularly with FITC-conjugated anti-IL-17, FITC-
conjugated anti-IFN-γ or PE-conjugated anti-IL-22 (BD Pharmingen or R&D) according to 
the protocols supplied by the manufacturers. The cells were measured on a FC500 flow 
cytometer (Beckman Coulter) and the data were analyzed using Kaluza 1.3.
Cytokine QTL mapping. Genotype and cytokine data could be generated for 391 healthy 
individuals. Gender information were coded either 0 for females or 1 for males. The actual 
age and coded gender information were included as co-variables in the linear regression 
model for cQTL mapping. Raw cytokine levels were log-transformed then correlated with 
genotype data. A nominal p value ≤ 0,05 indicates a suggestive cytokine QTL.
Patella washouts and cytokine measurements. Protein levels of murine IL-1β, IL-6 or 
KC were measured in patellae washouts. 4h after injection of 10^7 Borrelia spirochetes, 
patellae were isolated from inflamed knee joints and put in 0,05% Triton-X. After two freeze/
thaw cycles, supernatant was harvested and centrifugated for 5 minutes at 10000rpm. 
Cytokines were determined by Luminex technology, kits were obtained from Bio-Rad (USA).
Histological analysis. Whole knee joints were removed and fixed in 4% formaldehyde 
for 7 days before decalcification in 5% formic acid and processing for paraffin embedding. 
Tissue sections (7µm) were stained with Haematoxylin/Eosin. Histopathological changes in 
the knee joints were scored in the patellae/femur region.
Ethics statement. All human experiments were conducted according to the principles 
expressed in the Declaration of Helsinki. Before taking blood, informed written consent 
of each human subject was provided. The study was approved by the review board of 
Radboud University Nijmegen Medical Centre. 
Statistical Analysis. Data are expressed as mean ± SEM unless otherwise indicated. 
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Differences between experimental groups were tested using the two-sided Mann-Whitney 
U test performed on GraphPad Prism 4.0 software (GraphPad). P values of ≤0.05 were 
considered significant.
Results
Borrelia-induced joint inflammation is controlled by autophagy. As described before, 
autophagy modulates B. burgdorferi-induced cytokine responses in vitro. To assess its 
role in vivo, we induced murine Lyme arthritis by injecting live spirochetes into knee joints 
of WT or ATG7-deficient mice. Lyme arthritis, detected as joint swelling of the injected 
knee, could be seen in WT mice, but was significantly increased in ATG7 knock-out 
mice (Figure 1A). In addition to joint swelling, cytokine levels were measured in patella 
washouts. Significant differences in IL-1β, IL-6 and KC production could be detected 
when WT patellae were compared with ATG7-deficient patellae (Figure 1B-D). In addition, 
cell influx into the joint cavity at 4h was assessed. In WT mice, only few cells infiltrated 
into the joint cavity in contrast to ATG7-ko mice, in which more cells (mainly neutrophils) 
could be found (Figure 1E+F).
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Figure 1. Borrelia-induced cytokine 
production and cell influx is 
modulated by autophagy. (A) 
Macroscopic score of the knees in 
either wild-type (WT) (white bars), or 
ATG7 knockout mice (black bars) 24 
hours after intra-articular injection of 
1x10^7 live Borrelia species in 10 µl 
PBS. Data are mean ± S.E. from five 
animals in each group; **P <0.01; 
Mann-Whitney U test, two-tailed. (B-
D) 4 hours after i.a. injection of 1x 
10^7 live B. burgdorferi, patellae were 
cultured for 1 hour and IL-1β, IL-6 
and KC protein levels were measured 
using Luminex. Data are mean ± S.E.; 
5 animals in each group, *, p < 0.05; 
**, p < 0.01; Mann-Whitney U-test, 
two-sided. (E) Murine Lyme arthritis in 
WT, or ATG7 knockout mice. Histology 
(H&E staining) after i.a. injection of B. 
burgdorferi in knee joints. Left panel, 
WT; right panel, ATG7 knockout mice. 
JC, joint cavity; F, femur. 
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Time dependent cytokine production of PBMCs stimulated with B. burgdorferi. 
To investigate the effect of autophagy on B. burgdorferi induced adaptive cytokines, we 
first measured the inflammatory response to B. burgdorferi itself, analyzing the levels of 
secreted cytokines by PBMCs stimulated with B. burgdorferi in a time-dependent manner. 
After exposure to B. burgdorferi spirochetes, we observed an early increase of IL-1β, IL-
23, and TNF-α peaking after 24 hours (Figure 2A-C), as well as an increase in adaptive 
cytokines such as IL-17A, IL-17F, IL-22 and IFN-γ (Figure 2D-G).
Inhibition of autophagy enhances innate and adaptive cytokines production. 
Previously, the modulating effect of autophagy on B. burgdorferi-induced IL-1β has 
been shown (Figure 3A) [12]. Since IL-1Ra is a known natural antagonist of IL-1β, we 
investigated the effect of autophagy on its production next to other innate cytokines 
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Figure 2. Time-dependent cytokine pattern associated to 
stimulation with live B. burgdorferi. Freshly isolated human 
PBMCs were stimulated with B. burgdorferi (MOI 0.2) for 2h, 4h, 24h, 
48h, 4d or 7days. Cytokines were measured in the supernatants 
by specific ELISA.Histology (H&E staining) after i.a. injection of B. 
burgdorferi in knee joints. Left panel, WT; right panel, ATG7 knockout 
mice. JC, joint cavity; F, femur. 
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as IL-1α, TNF-α and IL-23. The inhibition of autophagy decreased the B. burgdorferi-
induced IL-1Ra production (Figure 3B), shifting the IL-1β/IL-1ra ratio to a more prominent 
inflammatory response (Figure 3C). Interestingly, the production of IL-1α and TNF-α 
are not affected by wortmannin (Figure 3E, F). The increased amount of IL-23 in B. 
burdorferi-stimulated autophagy-incapable cells (Figure 3D) led us to investigate the 
effect of autophagy on adaptive cytokines, since IL-23 and IL-1β have been shown to be 
important in the production of IL-17[8, 15]. As shown in Figure 3G-J, the production of IL-
17A, IL-17F, IL-22 as well as IFN-γ is significantly increased in autophagy-incapable cells 
stimulated with B. burgdorferi.
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Figure 3. Modulation of B. 
burgdorferi-induced inflammatory 
cytokine production by the 
inhibition of autophagy. Freshly 
isolated human PBMCs were 
preincubated for 1 h at 37 °C in 
culture medium in the presence or 
absence of the autophagy inhibitor 
wortmannin (100 nM), followed by 
stimulation with B. burgdorferi (MOI 
0.2) for 24 h (A-F) or 7 days (G-J). 
IL-1α, IL-1β, IL-1ra, TNF-α, IL-23, 
IL-17A, IL-17F, IL-22 and IFNγ were 
measured in the supernatants by 
specific ELISA. Bars represent mean 
± S.E. (error bars) of cells harvested 
from ten volunteers. *, p < 0.05; **, 
p < 0.01; ***, p < 0.0001, Mann-
Whitney U-test, two-sided.
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Inhibition of autophagy alters cytokine expression at the transcriptional level. To 
examine whether inhibition of autophagy during exposure to Borrelia results in altered 
mRNA levels, we measured transcription of several cytokines. After 24 hours, IL-1β and 
IL-23 mRNA levels were strongly increased in human Borrelia stimulated PBMCs when 
autophagy was inhibited (Figure 4A, B). As previously shown, the transcription of TNF-α 
was not altered (Figure 4C). The cytokine expression of IL-17A, IL-17F, IL-22 and IFN-γ 
was significantly increased after 4 days in autophagy-blocked cells (Figure 4D-G). 
The role of IL-1 and IL-23 in B. burgdorferi-induced IL-17, IL-22 and IFN-γ. In 
human PBMCs exposed to B. burgdorferi, IL-17 production is dependent on IL-1β and 
IL-23. To determine whether the increased cytokine response in autophagy-incapable 
cells was dependent on those cytokines, we blocked IL-1 and IL-23/IL-12 by specific 
antibodies before we stimulated the cells with B. burgdorferi in the presence or absence 
of wortmannin. As expected, IL-17 production was downregulated by inhibition of IL-1 and 
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Figure 4. Modulated expression 
of B. burgdorferi-induced 
inflammatory cytokines by the 
inhibition of autophagy. Freshly 
isolated human PBMCs were 
preincubated for 1 h at 37 °C in 
culture medium in the presence 
or absence of the autophagy 
inhibitor wortmannin (100 nM), 
followed by stimulation with B. 
burgdorferi (MOI 0.2) for 24 h 
(A-C) or 4 days (D-G). IL-1β, IL-
23, TNFα, IL-17A, IL-17F, IFNγ 
and IL-22 expression levels have 
been determined by RT-PCR. 
Bars represent mean ± S.E. (error 
bars) of cells harvested from 
10 volunteers. *, p < 0.05; **, p 
< 0.01; ***, p < 0.0001, Mann-
Whitney U-test, two-sided.
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IL-23 in B. burgdorferi-stimulated cells. Interestingly, the increase in the IL-17 production 
induced by autophagy inhibition was reduced in the presence of anti-IL-1 (Figure 5A), 
whereas the blockage of IL-23 had no effect (Figure 5B). The overall amount of IL-22 
and IFN-γ was decreased in the presence of IL-1 antibodies (Figure 5C+E), but only 
IFN-γ production was downregulated by anti IL-23/IL-12 (Figure 5F); no effect on IL-22 
production could be detected (Figure 5D). 
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Figure 5. Role of IL-1β and IL-23 on autophagy-modulated B. burgdorferi-induced T cell responses. IL-17 (A, 
B), IL-22 (C, D) and IFN-γ (E, F) were measured in culture supernatants of PBMCS stimulated with B. burgdorferi for 
7 days, in the presence or absence of the autophagy inhibitor wortmannin. IL-1 and IL-23/IL12 have been blocked by 
specific antibodies by 1 hour preincubation as indicated.
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Increase of Th17 cells is responsible for boosted B. burgdorferi-induced IL-17A in 
autophagy incapable cells. In order to further investigate cellular sources of IL-17, IL-22 
and IFN-γ in B. burgdorferi-stimulated cells, PBMCs were incubated for one week with 
the spirochete, before flow cytometry was performed for intracellular cytokines in CD4+, 
CD8+ or CD56+ cells. CD4+ cells are the main producers of B. burgdorferi-induced IL-17, 
whereas IFN-γ was produced by nearly equal amount of CD4+ and CD8+ cells. 12% of 
the overall IFN-γ production was due to CD56+ cells (Figure 6A). In addition, we wanted 
to assess whether the inhibition of autophagy increased a specific cell population that may 
be responsible for the increased cytokine response. A significant increase in CD4+IL-17+ 
cells (almost 50%) could be found in autophagy incapable cells stimulated with B. 
burgdorferi, explaining the increase in IL-17 production. Figure 6E demonstrates the 
increase of CD4+IL-17+ autophagy incapable PBMCs stimulated with B. burgdorferi. The 
percentages of CD8+IL17+ and CD56+IL-17+ cells did not differ between the stimulations 
(Figure 6B). Furthermore, no difference could be seen between the subpopulations being 
capable of producing IL-22 or IFN-γ (Figure 6C, D).
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CD4+ cells are the main producers of adaptive cytokines in response to B. 
burgdorferi. To proof our previous findings of the cellular sources of IL-17, IL-22 and 
IFN-γ, subpopulations known to be capable of producing these cytokines were depleted 
from the mixed cell population of PBMCs before exposure to B. burgdorferi in the 
presence or absence of wortmannin. For that purpose, cells expressing either CD4, CD8 
or CD56 were targeted. After depletion, equal numbers of regular PBMC or depleted 
cell populations were preincubated with RPMI or wortmannin before stimulation with B. 
burgdorferi. Notably, CD4 depletion suppressed production of IL-17, IL-22 and IFN-γ in 
response to spirochetes down to background levels (Figure 7A-C). 
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Figure 6. Cellular source of autophagy modulated T cell responses induced by B. burgdorferi. (A) Assessment 
of surface markers CD4, CD56 and CD8 to elucidate the contribution of different cell types to the population of IL-
17A+, IL-22+ and IFN-γ+ cells. (B-D) Comparison of the capacity of CD4+, CD8+ and CD56+ cells stimulated by B. 
burgdorferi in the presence or absence of wortmannin to produce the inflammatory cytokines IL-17, IFN-γ or IL-22. (E) 
Example of increased percentage of CD4+IL-17+ cells stimulated with B. burgdorferi in the presence of wortmannin 
compared to cells stimulated with B. burgdorferi in the absence of autophagy modulators.
Figure 7. T cell dependent production of IL-17A, IL-22 and IFN-γ by PBMCs exposed to live B. burgdorferi in 
the presence or absence of an autophagy inhibitor. After isolation, PBMCs were both depleted for CD4, CD8 or 
CD56 and stimulated with B. burgdorferi in the presence or absence of wortmannin. Release of IL-17, IL-22 or IFN-γ 
was determined by ELISA after 7 days. Data are expressed as means ± S.E. (error bars) of cells harvested from 10 
volunteers. *, p < 0.05; **, p < 0.01; ***, p < 0.0001, Mann-Whitney U-test, two-sided.
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CD8 depletion did only affect the amount of IFN-γ production, IL-17 and IL-22 were 
independent of the presence of CD8+ cells (Figure 7D-F). Depletion of CD56 had no 
effect on cytokine production at all (Figure7G-I).
cQTLs in ATG9B influence IL-17 production. Genetic factors are strongly influencing 
clinical disease outcome by having a huge regulatory impact on cytokine production [16]. 
Therefore, we assessed genetic variability in autophagy genes that influence Borrelia-
induced cytokine production. Cytokine quantitative trait loci (cQTL) analysis was performed 
as described previously [17]. Two SNPs in ATG9B (rs10266701 and rs13307588) show 
suggestive cQTL (p < 0.05) for Borrelia-induced IL-17 (Figure 8A+B) underlining our 
previous findings of the importance of autophagy for Borrelia-induced cytokines.
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Figure 8. SNPs in ATG9B affect IL-17 levels induced by B. burgdorferi. Genetic variants in ATG9B (rs10266701 
and rs13307588) modulates IL-17 levels induced by B. burgdorferi. Boxplots showing the association of genotypes at 
SNP (A) rs10266701(p=0,015) and (B)  rs13307588 (p=0,028) with B. burgdorferi induced IL-17 levels. The number 
of individuals per genotype is shown in parenthesis below each boxplot. 
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Discussion
The connection between autophagy and innate defense mechanisms has been made in 
several studies describing a regulatory role of autophagy on inflammasome activation and 
production of cytokines upon stimulation with microbial ligands [12, 18-20]. Furthermore, 
it has been shown that autophagy modulates the production of T-cell derived cytokines as 
IL-17, IL-22 and IFN-γ [13, 21], all cytokines known to be produced also after stimulation 
with B. burgdorferi [15, 22]. Since IL-17 has been associated to increase joint damage in 
rheumatoid arthritis patients [9] and elevated IL-17 levels have been found in patients with 
confirmed neuroborreliosis [23], we examined the role of autophagy on the production of 
T cell-derived cytokines in response to B. burgdorferi. 
In this study, we demonstrate that the secretion of adaptive inflammatory cytokines as IL-
17, IL-22 and IFN-γ is highly elevated in autophagy-incapable PBMCs in response to B. 
burgdorferi. IL-1β and IL-23 are needed to induce Th17 responses [24-26], and therefore 
we investigated the role of autophagy in the modulation of their production. Elevated 
levels of IL-23 were produced by PBMCs in response to B. burgdorferi when autophagy 
was inhibited. Previous studies have shown that IL-23 promotes the development and 
expansion of Th17 cells. However, IL-23 alone cannot drive differentiation of those cells 
from naïve CD4+ T cell precursors. IL-1β signaling also has a critical role during the initial 
stages of Th17 cell differentiation; it enhances the metabolic fitness of rapidly dividing 
Th 17 cells during inflammation by the induction of phosphorylation of mTOR[27]. In our 
experiments, both cytokines are present to induce the development of IL-17. Apparently, 
the presence of IL-23 is important to promote the development of Th17 cells, but IL-1β is 
the key driver of the amount of IL-17 produced.
A previous study by Strle et al. [28] has shown elevated levels of IL-23 in patients 
with post-Lyme disease symptoms and elevated levels of IL-17 have been found in 
cerebrospinal fluid of neuroborreliose-patients [23]. It has been suggested that Th17 cells 
and their associated cytokines are involved in the pathogenesis of Lyme arthritis [11, 29, 
30]. Defective autophagy would explain an increased Th17 response which might be 
associated to an increase in severity of disease symptoms.
Using flow cytometric analysis of PBMCs and depletion of CD4, CD8 or CD56 T-cell 
subsets, we determined that both cytokines IL-17 and IL-22 are primarily produced by 
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CD4+ T cells in response to B. burgdorferi stimulation. Next to its production by CD4+ 
cells, we were able to demonstrate that a significant number of CD8+ and CD56+ cells 
express IFN-γ in response to B. burgdorferi, which is in line with a previous report [31]. 
However, in contrast to this previous study, depletion of CD56+ cells did not alter B. 
burgdorferi-induced IFN-γ responses. Furthermore, the IFN+CD56+ cells did not expand 
upon stimulation with B. burgdorferi. These data suggest that NK cells do not have a 
major contribution to the IFN-γ response to Borrelia in this setting.
Next to our in vitro data, we injected B. burgdorferi into the knee joints of ATG7 deficient 
mice, showing increased joint swelling and more cell influx compared to WT mice. It 
is known that the genetic background of mice influences the susceptibility for several 
experimental disease models including the induction and maintenance of experimental 
murine Lyme disease. C57Bl/6 mice clear the infection very fast, which explains the mild 
joint swelling and hardly any cell influx due to the bacteria. Long-term effects on IL-17 
production could not be measured since the infection is cleared soon after injection of 
the bacteria. To study the effect of autophagy on adaptive cytokines in mice, an ATG-
knockout needs to be developed in a mouse strain that is more susceptible to Borrelia 
infection, such as the C3H/H3N mice. 
In summary, we have demonstrated a regulatory link between autophagy and T-cell 
cytokine production in response to B. burgdorferi stimulation, which is dependent on IL-1 
but not on IL-23 secretion. These findings further highlight autophagy as a potential target 
for anti-inflammatory therapies in Lyme disease.
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Abstract
We have previously demonstrated that inhibition of autophagy increased the Borrelia 
burgdorferi induced cytokine production, but little is known about the molecular pathway 
behind this phenomenon. Here, by integrating transcriptional analysis and functional 
genomics, we identified the key players of autophagy-related genes which were 
modulated by stimulation with the Borrelia spirochete. To confirm the clinical relevance 
of these findings, we investigated the expression of autophagy-related genes in Lyme 
disease patients and compared the results to healthy controls. Several genes were 
differentially expressed highlighting the importance of the autophagy machinery during 
the course of Lyme disease. In addition, we identified around 200 cQTLs in autophagy-
related genes that modulated the Borrelia-induced cytokine production. Since increased 
levels of cytokines as IL-17 have been found in patients with confirmed severe forms of 
borreliosis, we propose that the modulation of autophagy may be a potential target for 
anti-inflammatory therapy in patients with persistent Lyme Disease.
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Introduction
Lyme disease, the most common vector-borne disease in the United States and Western 
Europe, is caused by spirochetes of the species Borrelia burgdorferi sensu lato [1]. The 
tick-born disease presents itself under a wide variety of clinical manifestations ranging 
from early localized symptoms as erythema migrans to more persistent ones involving a 
patient’s skin (B. afzelii),  joints (B. burgdorferi) or nervous system (B. garinii) [2,3]. 
The host’s immune response against B. burgdorferi is regulated by several cytokines 
including IL-1β and IL-17 [4-6]. Both cytokines have a broad range of functions as mediating 
inflammation in protective immunity to infectious diseases, but are also responsible for 
hyperinflammation in diseases associated with a dysregulated immune response as 
increased joint damage in rheumatoid arthritis [7]. Recognition of spirochetes by different 
pattern recognition receptors lead next to the production of cytokines, also to the induction 
of autophagy, a process associated to the degradation of damaged organelles or protein 
[8]. When its signaling pathways are activated, autophagy starts with an ensemble of 
autophagy (ATG) factors inducing the formation of an isolation membrane. Thereafter, an 
autophagosome is formed, fuses with a lysosome to create an autolysosome, followed by 
the degradation of the cargo and release of degraded products back into the cytosol [9]. 
In addition to its known function, autophagy has been shown to regulate the production of 
inflammatory cytokines and immune responses in infection [10,11].  
Assessment of clinical symptoms and immune characteristics of Borrelia-infected patients 
illustrates a large diversity in the size of EM lesions as well as in cytokine levels which 
have been associated to genetic variations in these patients leading to differences in 
clinical outcome [12,13]. Despite the importance of immune variation for the outcome of 
disease, only few studies have looked into genetic factors influencing cytokine production 
induced by B. burgdorferi [13]. In this report, we investigated the role of genetic variations 
in autophagy genes and their effect on Borrelia-induced cytokine responses. Different 
expression profiles of ATG genes could be found in Lyme disease patients compared to 
healthy controls. Furthermore, genetic variants of autophagy genes could be associated 
to different levels of Borrelia-induced cytokines. These findings underline the important 
role of autophagy in the pathogenesis of Lyme disease, suggesting that modulation of 
autophagy could be a novel target in the course of treatment of Lyme disease patients. 
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Material & Methods
B. burgdorferi cultures. B. burgdorferi, ATCC strain 35210, was cultured at 33°C in
Barbour-Stoenner-Kelley (BSK)-H medium (Sigma-Aldrich) supplemented with 6% rabbit
serum. Spirochetes were grown to late-logarithmic phase and examined for motility by dark-
field microscopy. Organisms were quantitated by fluorescence microscopy after mixing
10 µL aliquots of culture material with 10 µL of an acridine orange solution and counted
using a Petroff-Hauser counting chamber. Bacteria were harvested by centrifugation of
the culture at 7000 x g for 15 min., washed twice with sterile PBS (pH 7.4), and diluted in
the specified medium to required concentrations of 1×106 spirochetes per ml.
Isolation of human peripheral blood mononuclear cells and in vitro cytokine 
production. Venous blood was drawn from the cubital vein of healthy volunteers into 10 
ml EDTA tubes (Monoject, Covidien, Mansfield, Massachusetts, USA). The mononuclear 
cell fraction was obtained by density centrifugation of blood diluted 1:1 in pyrogen-free 
saline over Ficoll-Paque (Pharmacia Biotech, Pittsburgh, Pennsylvania, USA). Cells were 
washed twice in saline and suspended in culture medium (RPMI; Invitrogen, Carlsbad, 
California, USA) supplemented with gentamicin 50 mg/ml, L-glutamine 2 mM and pyruvate 
1 mM. Cells were counted in a Coulter counter (Coulter Electronics, Brea, California, 
USA) and the number was adjusted to 5x106 cells/ ml. A total of 5x105 mononuclear cells 
in a 100 µl volume was added to round-bottom 96-well plates (Greiner, Monroe, North 
Carolina, USA) and incubated with either 100 µl of culture medium (negative control), 
or B. burgdorferi (106 spirochetes per ml). At indicated time points, supernatants were 
collected and stored at −20°C until being assayed.
Cytokine measurements. Concentrations of human IL-1β, IL-6, TNFα, IL-17, IL-22, 
or IFNγ were determined in duplicates using specific commercial ELISA kits (Sanquin, 
Amsterdam, or R&D Systems, Minneapolis), in accordance with the manufacturers’ 
instructions.
RNA sequencing. RNA sequencing data was obtained after stimulation of PBMCs 
with RPMI or B. burgdorferi for 4 hours. Sequencing reads were mapped to the human 
genome using STAR (version 2.3.0) [14]. The aligner was provided with a file containing 
junctions from Ensembl GRCh37.71. Htseq-count of the Python package HTSeq (version 
0.5.4p3) was used (The HTSeq package, http://wwwhuber.embl.de/users/anders/HTSeq/
Chapter 5
5
89
doc/overview. html) to quantify the read counts per gene based on annotation version 
GRCh37.71, using the default union-counting mode. Differentially expressed genes 
were identified by statistics analysis using DESeq2 package from bioconductor [15]. The 
statistically significant threshold (FDR P ≤ 0.05 and Fold Change ≥2) was applied.
Pathway enrichment analysis. Pathway enrichment analysis was performed using the 
Cytoscape app ClueGO [16]. Enrichment in a set of selected genes was checked for 
all path ways present in the Wiki-pathways and Reactome databases compared to a 
background set of all genes for which differential expression was calculated. Analysis 
was performed separately for the sets of up and down regulated genes. Pathways with 
a corrected (enrichment) P-value smaller than 0.05 are considered significant. P values 
were corrected using the Bonferroni step down algorithm built into the ClueGO app.
Lyme disease patients. RNAsequencing data of acute Lyme patients was obtained 
from a publicly available dataset ([17], accession number GSE63085) through the Gene 
Expression Omnibus (GEO) data repository. Expression of selected genes was compared 
between erythema migrans (EM) patients at different time points and healthy controls by 
Kruskal-Wallis one-way ANOVA with Dunn’s post-hoc test-T.
Genotyping, quality control and imputation. DNA samples were genotyped 
as previously described [13] using the commercially available SNPchip, Illumina 
HumnaOmniExpressExome-8 v1.0. 
Cytokine QTL mapping. Genotype and cytokine data could be generated for 391 healthy 
individuals. Gender information were coded either 0 for females or 1 for males. The actual 
age and coded gender information were included as co-variables in the linear regression 
model for cQTL mapping. Raw cytokine levels were log-transformed then correlated with 
genotype data. A nominal p value ≤ 0.05 indicates a suggestive cytokine QTL.
Ethics statement. All human experiments were conducted according to the principles 
expressed in the Declaration of Helsinki. Before taking blood, informed written consent 
of each human subject was provided. The study (nr. 42561.091.12) was approved by the 
review board of Radboud University Medical Centre, Nijmegen, The Netherlands. 
Statistical Analysis. Data are expressed as mean ± SEM unless otherwise indicated. 
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Differences between experimental groups were tested using the two-sided Mann-Whitney 
U test performed on GraphPad Prism 4.0 software (GraphPad). P values of ≤0.05 were 
considered significant.
Results
B. burgdorferi stimulation induces the transcription of autophagy-related 
proteins. To identify new targets for the treatment of Lyme disease, we investigated 
the transcriptional profile of B. burgdorferi-stimulated human PBMCs. Transcriptomic 
assessment of these PBMCs by RNA sequencing (Figure 1A) and pathway analysis 
(Figure 1B) revealed specific clusters of genes significantly induced by B. burgdorferi-
stimulation with an intriguing signal found in genes associated to autophagy. 
Therefore, we focused on autophagy related genes, to find the key players involved during 
the pathogenesis of Borrelia-infection. As shown in Figure 2A, 36 genes associated to 
autophagy were analyzed for up or downregulation in response to Borrelia-infection, 
whereof 12 genes were found to be significantly regulated (Figure 2B).  
Autophagy genes are differentially expressed in Lyme disease patients. To further 
investigate the clinical impact of autophagy in Lyme disease, we looked into different 
expression profiles of autophagy-related genes in Lyme disease patients and compared 
the outcome to healthy controls. ATG3 (Figure 3A) and ATG7 (Figure 3B) were both 
significantly increased in patients compared to healthy controls. ATG9, ATG16L1 and 
mTOR expression (Figure 3C-F) were significantly downregulated in early Lyme disease 
patients (up to 3 weeks post Borrelia infection), but background levels were reached 
after 6 months post-infection. The results are in line with previous in vitro stimulation 
data, showing up- and downregulation of autophagy related genes due to B. burgdorferi 
stimulation.
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Figure 1. Transcriptional responses 
to B. burgdorferi. (A) Heatmap 
showing the log2fold-changes of B. 
burgdorferi-regulated genes after 4 
hours of stimulation. Eight replicates 
are shown separately on the x-axis. 
Color intensities correspond to 
the log2fold-changes as indicated 
in the legend (red=upregulation, 
green=downregulation). (B) Pathway 
enrichment analysis was performed 
using the Cytoscape app ClueGO. Top 
100 up and down regulated genes were 
analyzed separately for their pathway 
enrichment; the results are combined in 
this figure. Green circles correspond to 
enrichment in the set of down-regulated 
genes, whereas red circles indicate sets 
of up-regulated genes. Lines between 
pathway terms indicate similar sets of 
enriched genes. 
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Figure 2. Expression of autophagy 
genes after Borrelia burgdorferi 
recognition. (A) Heatmap showing 
fold-changes for a selected set 
of autophagy genes, with each of 
the replicates shown separately. 
Genes are sorted top to bottom 
with decreasing P-values. (B) 
Table showing autophagy genes 
significantly up and downregulated by 
B. burgdorferi.
Figure 3. Autophagy gene expression profiles in Lyme patients compared to healthy controls. The expression 
of several autophagy genes – (A-F) ATG3, ATG7, ATG9A, ATG9B, ATG16L1 and mTOR - in PBMCs isolated from 
heathy controls and patients showing erythema migrans (time points: 0, 3 weeks, 6 months) were analyzed. Bars 
represent mean ± S.E.M. (error bars) of cells harvested from 13 healthy controls and 28 patients. *, p < 0.05; **, p < 
0.01, Mann-Whitney U-test, two-sided.
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cQTLs in autophagy-related genes influence Borrelia-induced cytokine production. 
Genetic factors are strongly influencing clinical disease outcome by having a large 
regulatory impact on cytokine production [12]. Therefore, we assessed genetic variability 
in autophagy genes that influence Borrelia-induced cytokine production. Cytokine 
quantitative trait loci (cQTL) analysis was performed as described previously [13]. Almost 
200 SNPs in autophagy related genes were found to modulate Borrelia-induced cytokine 
production (Supplementary Figure 1) underlining our previous findings of the important 
functional correlation between autophagy and Borrelia-induced cytokine production. Two 
SNPs in ATG7 and ATG9B (rs73019544 and rs11760487) are shown exemplarily as 
suggestive cQTLs (p < 0.05) for Borrelia-induced IL-1β (Figure 4A+B). Figure 4C shows 
four SNPs with the most significant effects on Borrelia-induced innate cytokines as IL-1β 
and IL-6, Figure 4D shows the effect on adaptive cytokines as IL-17, IL-22 and IFNγ. 
To visualize the effect of different autophagy-related genes on Borrelia-induced cytokine 
production, a schematic overview of the autophagic machinery is shown in Figure 5, 
highlighting those genes modulating Borrelia-induced cytokine production, both innate- 
as well as adaptive-related cytokines. 
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Figure 4. Genetic variants 
in autophagy genes are 
associated with B. burgdorferi-
induced cytokine levels. 
Boxplots showing the association 
of genotypes at SNP (A) 
rs73019544 (p=0,033) and (B) 
rs11760487 (p=0,038) with B. 
burgdorferi induced IL-1β levels. 
The number of individuals per 
genotype is shown in parenthesis 
below each boxplot. (C-D) List of 
SNPs in autophagy genes which 
influence B. burgdorferi-induced 
cytokine production after (C) 24 
hours and (D) 7 days (four most 
significant SNPs per cytokine).
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Discussion
Lyme disease patients show a large diversity between their clinical symptoms ranging 
from distinctions in size and number of erythema migrans lesions up to secondary 
manifestations involving the central nervous systems, skin alterations and inflammatory 
joint swelling. Approximately 10 to 20% of patients report persistent symptoms lasting 
months to years [17]; why the other 80 % of patients don’t suffer from continuing symptoms 
is not known. Although the connection between genetic variation and diverse cytokine 
responses leading to differences in clinical outcome has been made, little is known about 
the molecular pathways involved in this phenomenon. 
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Figure 5. Schematic overview of autophagy genes influencing B. burgdorferi-induced cytokine responses. 
Initiation of autophagy begins with the formation of the isolation membrane. Further elongation and autophagosome 
completion requires different complexes of autophagy proteins, e.g. ATG5-ATG12-ATG16L-complex as well as the 
PE-conjugated microtubule-associated protein1 light chain 3 (LC3). SNPs in autophagy genes (indicated in red) have 
been shown to be responsible for differences in B. burgdorferi-induced cytokines. 
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In our approach, we designed a set of experiments assessing the transcriptional profile 
induced in circulating leukocytes by B. burgdorferi. Human primary PBMCs were 
stimulated either with RPMI or Borrelia spirochetes. Pathway analysis of genes induced 
by Borrelia indicated an upregulation of expected pathways involved in inflammation 
and innate immunity, but also a modulated expression of genes involved in autophagy. 
Previous studies have already described an altered cytokine profile of Borrelia-stimulated 
autophagy-incapable PBMCs [8,11]. To confirm this finding and to find the key players 
involved in this process, we looked into the expression of autophagy-related genes. 
Significant up- and downregulation of several autophagy-related genes as ATG7, ATG9 
and ATG16L was found. Polymorphisms in ATG genes have been associated with 
autoimmune disorders as lupus erythematosus (SLE) [18], Crohn’s diseases [19,20] and 
rheumatoid arthritis [21] indicating the clinical relevance of autophagy in immunological 
and inflammatory disorders.
To confirm these findings, we compared different expression profiles of autophagy-
related genes in 29 Lyme disease patients to 13 matched controls. We identified several 
differentially expressed autophagy-related genes indicating a relevant role for those 
genes in the pathogenesis of the disease.
Analyzing the results, we found some autophagy-related genes to be upregulated, 
others downregulated in the process of the disease. Unfortunately, it is not known 
which modulated gene has the highest impact on the process of autophagy. It has been 
described that autophagy involves multiple molecular components, including the (1) ULK1 
complex [22]; (2) the PI3K complex [23]; (3) transmembrane proteins as ATG9 [24]; (4) 
ubiquitin-like conjugation systems, involving ATG12 and LC3 [25]; as well as (5) several 
lysosomal hydrolases [26]. It is possible to speculate that the individual components 
of the autophagy machinery are differentially expressed depending on the time point 
of measurement. The downregulation of the autophagy suppressor mTOR, which is 
associated to the ULK1 complex, is in line with previous studies showing the induction 
of autophagy by B. burgdorferi stimulation [8,11]. ATG3 and ATG7, both upregulated in 
patients showing erythema migrans lesions, are components of the LC3 Conjugation 
System indicating as well an induction of autophagy by B. burgdorferi stimulation. ATG9 
and ATG16L belong to different molecular components of the autophagy machinery, 
taking place on different time points which could explain their downregulation in Lyme 
disease patients at the moment of measurement. 
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Although most ATG proteins seem to be involved mainly in autophagy, some of them 
have been shown to exhibit nonautophagic functions as the participation in mitochondria 
homeostasis [27] or antiviral responses [28]. But the conclusion that autophagy is involved 
in the course of Lyme disease is not based on the regulation of one autophagy-related 
gene. Several autophagy genes are regulated by B. burgdorferi in our study; previous 
studies using pharmacological inhibitors of autophagy are also in line with our data [8,11]. 
Since cytokine responses are crucial in the pathophysiology of Lyme disease, we looked 
into the effect of autophagy genes on the production of cytokines. We have identified 
cQTLs in autophagy-related genes that strongly influence Borrelia-induced innate and 
adaptive cytokine production. Previous studies have already described the important role 
of IL-1β in the pathogenesis of Lyme disease. Early symptoms as low-grade fever and 
malaise can be mediated by this cytokine [4,29] and high amounts of this cytokine were 
found near the location of erythema migrans lesions after tick bites [30]. IL-1β induces in 
synergy with IL-23 the production of IL-17 and related cytokines from Th17 cells [10,31], 
which have been associated to increased joint damage in rheumatoid arthritis or psoriasis 
patients [7,32]. The role of adaptive cytokines such as IL-17 and IL-22 during the course 
of Lyme disease has not been fully understood yet, but there are some indications that 
both cytokines play a role in the persistent phase of the disease [33-35]. Single nucleotide 
polymorphisms (SNPs) in autophagy genes modulating the expression of those adaptive 
cytokines could be one explanation for the different disease outcome [36-38].
The incidence of Lyme disease has increased in the past few years [39], pointing to the 
urgency of new developments in treatment options. In our study, we have demonstrated 
a regulatory link between autophagy and B. burgdorferi-induced cytokines highlighting 
autophagy as a potential target for anti-inflammatory therapies in Lyme disease.
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Supplementary figure 1. List of SNPs in autophagy genes which influence B. burgdorferi-induced cytokine 
production after 24 hours (IL-1β, IL-6, TNFα) and 7 days (IL-17, IL-22 and IFNγ).
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Abstract
The anti-tuberculosis-vaccine Bacillus Calmette-Guérin (BCG) is the most widely used 
vaccine in the world. In addition to its effects against tuberculosis, BCG vaccination 
also induces non-specific beneficial effects against certain forms of malignancy and 
against infections with unrelated pathogens. It has been recently proposed that the non-
specific effects of BCG are mediated through epigenetic reprogramming of monocytes, 
a process called trained immunity. In the present study we demonstrate that autophagy 
contributes to trained immunity induced by BCG. Pharmacologic inhibition of autophagy 
blocked trained immunity induced in vitro by stimuli such as β–glucans or BCG. Single 
nucleotide polymorphisms (SNPs) in the autophagy genes ATG2B (rs3759601) and 
ATG5 (rs2245214) influenced both the in vitro and in vivo training effect of BCG upon 
restimulation with unrelated bacterial or fungal stimuli. Furthermore, pharmacologic or 
genetic inhibition of autophagy blocked epigenetic reprogramming of monocytes at the 
level of H3K4 trimethylation. Finally, we demonstrate that rs3759601 in ATG2B correlates 
with progression and recurrence of bladder cancer after BCG intravesical instillation 
therapy. These findings identify a key role of autophagy for the nonspecific protective 
effects of BCG.
Author Summary 
Next to its effects against tuberculosis, BCG vaccination also induces non-specific 
beneficial effects on immune cells to increase their ability to control unrelated pathogens. 
It has been recently proposed that the non-specific effects of BCG are mediated through 
epigenetic reprogramming of monocytes, a process called trained immunity.  Little 
is known regarding the intracellular events controlling its induction. In this study we 
identified autophagy as a key player in trained immunity. Pharmacological inhibition of 
autophagy as well as polymorphisms in autophagy-related genes blocked BCG-induced 
trained immunity. Furthermore, BCG vaccine is also used to treat bladder cancer. Genetic 
polymorphisms in autophagy-related genes correlated with progression and recurrence 
of bladder cancer after treatment with BCG therapy. These findings open new possibilities 
for improvement of future BCG-based vaccines to be used against infections and 
malignancies.
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Introduction
Immunological memory has long been viewed as being exclusively mediated by T and B 
cells. However, an increasing body of evidence indicates enhanced nonspecific protection 
against reinfections in plants [1] and insects [2] which lack adaptive immunity. Similarly, 
mammalian innate immune cells such as natural killer cells show features of immunological 
memory [3,4]. Recently, we proposed the term trained immunity to describe the memory 
properties of innate immune cells [5]. Candida albicans or its major cell wall component 
β-glucan, as well as BCG, are prominent stimuli that can induce trained immunity through 
epigenetic reprogramming of monocytes [6,7]. However, little is known regarding the 
intracellular events controlling the induction of trained immunity, impairing the ability to 
fully harness the therapeutic potential of this important immunological process. Therefore, 
we investigated the trained immunity-induced signaling pathways, discovering autophagy 
being one of the main players.
Results 
β-glucan training induces the transcription of autophagy-related proteins. To identify 
new signaling pathways specifically activated upon training of monocytes with bacterial 
components, we compared the transcriptional profile of β-glucan-trained human primary 
monocytes isolated from healthy volunteers to the profile of monocytes stimulated with 
Escherichia coli-derived lipopolysaccharide (LPS), which stimulates inflammation but is 
unable to induce long-term training [5]. Transcriptomic assessment of these monocytes 
by microarrays and pathway analysis revealed specific clusters of genes significantly 
induced by β-glucan training with an intriguing signal found in the ubiquitin-related proteins 
and associated catabolic processes (Figure 1A). Since ubiquitination plays an important 
role in autophagy [8], a process that has previously been shown to improve intracellular 
processing of BCG [9,10], we examined the role of autophagy in the induction of trained 
immunity.
Autophagy is essential for β-glucan and BCG training in monocytes. Using an in 
vitro model of trained immunity [6,7], adherent monocytes from healthy human volunteers 
were stimulated for 24h with RPMI, BCG or β-glucan alone or in combination with the 
autophagy inhibitors 3-methyladenine (3MA) or wortmannin. After washing of cells and 
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a resting period of 6 days in medium supplemented with 10% human serum, cytokine 
production was measured after a second stimulation with the unrelated stimuli LPS or 
Borrelia burgdorferi (B. burgdorferi) (Figure 1B). IL-6 and TNF-α production increased 
significantly in BCG- and β-glucan-trained cells compared to non-trained cells. When 
autophagy was blocked by 3MA or wortmannin, neither β–glucan nor BCG induced 
trained immunity (Figure 1C–F; Figure S1A-H). Notably, the putative cytotoxic effects 
of autophagy inhibitors used in this study were assessed by LDH measurements. None 
of the inhibitors used during the 24h of primary cell stimulation enhanced LDH release 
compared to RPMI-treated cells (Figure S2 A-C), demonstrating that the molecules were 
not toxic to the cells.
Single nucleotide polymorphisms in ATG2B and ATG5 negatively influence trained 
immunity. To further explore the role of autophagy in the nonspecific protection of BCG 
in innate immune cells, we examined the effects of genetic polymorphisms in autophagy 
genes for the BCG-induced trained immunity in vitro and in vivo. The genotypes of nine 
SNPs in eight autophagy genes were correlated with the capacity of BCG to induce 
trained immunity in a group of 72 volunteers. The rs3759601 ATG2B SNP was found to 
be strongly associated with trained immunity; the ability to develop training characteristics 
following BCG treatment was observed in monocytes isolated from individuals carrying 
the GG (major) or CG genotype but not in those carrying the CC (minor) genotype (plus 
strand coding) (Figure 2A-F). A similar effect, though less clear, was apparent for the 
rs2245214 ATG5 SNP (Figure 2G-I). No significant association was found between the 
nonspecific protection of BCG and polymorphisms in ATG10, ATG16L1, EREG, IRGM, 
LAMP3 and WIPI (Figure S3).
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Figure 1. Role of autophagy for the training of monocytes. (A) Transcriptome profiling and pathway analysis 
of β-glucan training of monocytes compared to LPS stimulation. Factorial design analysis was performed on genes 
in each K-means cluster to assess significance of response differences elicited by LPS and β-glucan (Benjamini-
Hochberg (BH)-adjusted p < 0.05). The signal:noise ratio is shown as heatmaps.  Functional enrichment (or molecular 
concept) map was generated for genes exhibiting significantly weaker LPS response relative to β-glucan response. 
This map summarizes the extent of mutual overlap between gene sets and identifies a cluster of strongly connected 
gene sets that are enriched among genes showing stronger β-glucan response. Only enriched gene sets in the 
significant range with gene set enrichment score (-Log10(p)>1.3; p<0.05) are shown.  Nodes denote enriched gene 
sets or „annotation terms/categories“, assembled from (K) KEGG pathways, (G) Gene Ontology, (P) Panther pathways, 
(R) Reactome. Node size corresponds to the number of gene members in each gene set. Node color denotes the gene 
set enrichment score.  Please refer to graphical legend (boxed) in figure. The extent of mutually overlapping genes 
between gene sets is represented by thickness and color intensity of edges connecting nodes. The overlap score is
the average of the Jaccard and Overlap coefficients.  Strongly connected network components were identified using 
Tarjan’s algorithm. Important ubiquitin-related processes in map are highlighted.  (B) Diagram showing the course of the 
in vitro preincubation experiment. (C-F) BCG (C-D) or β-glucan (E-F) training in vitro in the presence or absence of 3MA 
using freshly isolated human monocytes and different stimuli for restimulation (LPS, B. burgdorferi). *P<0.05, **P<0.01.
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Figure 2. Polymorphisms in ATG2B or ATG5 diminish the training capacity of human monocytes. (A-I) Blood 
was collected from volunteers and genotyped for ATG2B rs3759601 (A-F) and ATG5 rs2245214 (G-I). Human 
monocytes were trained with BCG for 24 h, washed and incubated in RPMI (10% human serum) for 6 d, after which 
they were restimulated for 24h with a second stimulus (LPS, Bb, or C. albicans). Proinflammatory cytokine production 
(IL-6 and TNF-α) was assessed by ELISA in the supernatants. (J-K) PBMCs isolated from volunteers carrying different 
genotypes for SNPs rs3759601 or rs2245214 were stimulated for 24 h with LPS or B. burgdorferi. IL-6 was measured 
in the supernatants by ELISA. (L) Human monocytes carrying different genotypes for SNP rs3759601 were trained with 
BCG for 4h. Expression of ATG2B was assessed by qPCR *P<0.05, **P<0.01.
110
To test the possibility that the association between SNPs and differences in cytokine 
production of BCG-trained monocytes was due to differential intrinsic capacity of the cells to 
produce cytokines, we stimulated monocytes bearing different ATG2B (Figure 2J) or ATG5 
(Figure 2K) alleles with LPS or B. burgdorferi for 24 hours. We noted no differences in 
cytokine release, indicating that the capacity of cells to release proinflammatory cytokines 
upon stimulation was not responsible for the observed association between autophagy SNPs 
and BCG-induced trained immunity. Next to that, the effect of the rs3759601 SNP on the 
transcription of the ATG2B gene was assessed after training. We observed increased levels 
of ATG2B transcripts in BCG-trained cells of individuals carrying the GG genotype but not 
in those carrying the CC genotype (Figure 2L). Increased ATG2B levels could also be found 
in β-glucan trained individuals carrying the GG genotype (Figure S4A) but no difference in 
ATG2B levels could be found in the two groups after LPS stimulation (Figure S4B). The 
reduced  expression of ATG2B in individuals carrying the CC genotype of the SNP upon 
training with BCG could indicate a role for autophagy in trained immunity since it has been 
shown that the ATG2 proteins are essential for the formation of autophagosomes [11].
Autophagy is influenced by ATG2B single nucleotide polymorphism. To identify the 
effect of rs3759601 in ATG2B on autophagy, the amount of LC3+ vesicles in BCG stimulated 
monocytes of individuals carrying the major or minor variant of the SNP have been compared. 
A decrease in autophagosome formation of individuals carrying the CC genotype can be 
seen as demonstrated by a lower percentage of LC3+ monocytes (Figure 3A-B).
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Figure 3. Autophagy affected by SNP in ATG2B. (A-B)Monocytes genotyped for ATG2B rs3759601 were seeded 
on coverslips, and stimulated with BCG. After 1 hour of stimulation, cells were fixed and stained with an antibody 
against LC3. 
111
ATG2B single nucleotide polymorphism influences in vivo training of monocytes. 
To corroborate the above data, we investigated BCG-induced training of monocytes in vivo 
by testing individuals carrying different ATG2B alleles. Monocytes were isolated from 16 
healthy volunteers, before and 3 months after vaccination with BCG. Following stimulation 
with LPS (Figure S5A-B) or B. burgdorferi (Figure 4A-B), IL-1β and TNF-α production was 
significantly higher 3 months after vaccination in individuals who were bearing at least one 
G allele of the ATG2B SNP (n=12), while monocytes isolated from individuals carrying 
the CC genotype (n=4) showed no change in cytokine production after BCG vaccination.
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Figure 4. SNP in ATG2B affects the 
efficacy of in vivo BCG-induced 
trained immunity. (A-B) Monocytes 
isolated before and 3 months after 
vaccination of 16 naïve (nonexposed) 
volunteers were stimulated in vitro 
with B. burgdorferi. Proinflammatory 
cytokine production (IL-1β [A], TNF-α 
[B]) was assessed by 
ELISA in the supernatants. 
(C-D) Kaplan-Meier 
curves for recurrence-free 
(C) and progression-free 
(D) survival according to 
rs3759601 SNP genotype 
of 192 patients suffering 
from non-muscle invasive 
bladder cancer treated 
with ≥6 intravesical 
instillations of BCG. Each 
drop in a probability curve 
indicates one or more 
events in that group. 
Vertical lines indicate 
censored patients, i.e. 
those who reached the 
end of their follow-up 
without experiencing 
the event. Total number 
of patients and number 
of events (between 
brackets) per genotype 
category are indicated 
next to the corresponding 
curve. Numbers of 
patients at risk at selected 
time points for each 
genotype category are 
given below the plots. 
(E-G) Monocytes of 
bladder cancer patients 
isolated before and 
after 6 intravesical BCG 
instillations as initial 
treatment were stimulated 
in vitro with LPS. 
Proinflammatory cytokine 
production (IL-1β [E], 
IL-6 [F], TNF-α [G]) was 
assessed by ELISA in the 
supernatants *P<0.05, 
**P<0.01.
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SNP in ATG2B correlates with the progression and recurrence of bladder cancer 
after BCG intravesical instillation therapy. In addition to the protective effects of BCG 
against secondary infections, non-specific therapy with intravesical BCG is also used as a 
therapeutic strategy for patients with non-muscle invasive bladder cancer (NMIBC; stages: 
Ta, T1, CIS) [12]. In a cohort of 192 NMIBC patients treated with at least 6 intravesical 
instillations of BCG we evaluated the association between the ATG2B SNP and prognosis 
in terms of recurrence and progression during the first five years after the primary NMIBC 
diagnosis. Analyses learned that those patients that carry one or two C alleles for ATG2B 
rs3759601 showed increased risk of recurrence (CG vs. GG: hazard ratio (HR) =  1.73 
(95% confidence interval (CI): 0.99-3.03) and CC vs. GG: HR = 1.68 (95% CI: 0.78-3.27)) 
(Figure 4C) and progression (CG vs. GG: HR = 1.57 (95% CI: 0.79-3.12) and CC vs. GG: 
HR = 2.15 (95% CI: 1.00-4.66)) (Figure 4D). This finding of a correlation between the 
polymorphism in ATG2B to progression and recurrence of bladder cancer supports the 
hypothesis of a clinical relevance of the autophagy gene for the non-specific protective 
effects exerted by BCG. In addition, the responsiveness of circulating monocytes of 
bladder cancer patients has been investigated before and after BCG-therapy. Of high 
interest, individuals who received intravesical BCG therapy showed an increased cytokine 
response of their monocytes after stimulation with LPS in vitro (Figure 4E-G).
Pharmacologic or genetic inhibition of autophagy blocks epigenetic reprogramming 
of monocytes in response to BCG training. Epigenetic reprogramming of monocytes 
is a crucial immunological mechanism underlying nonspecific protection by BCG. 
Stable changes in histone trimethylation at the level of lysine 4 of histone 3 (H3K4), a 
post-translational modification associated with the regulation of immune-related genes 
[13], is one of the mechanisms responsible for enhanced cytokine production after re-
stimulation of trained monocytes [5-7]. Therefore, we assessed whether trimethylation of 
H3K4 due to nonspecific training by BCG was influenced by the ATG2B polymorphism 
or inhibition of autophagy by 3MA. Consistent with our hypothesis, H3K4 trimethylation 
was significantly increased at the IL-6 and TNF-α promoters in BCG-trained monocytes 
from volunteers bearing the ATG2B G allele (Figure 5A-B). In contrast, volunteers 
homozygous for the ATG2B C allele did not show any increase in trimethylation at H3K4 
at the cytokine promoters after BCG-training. Furthermore, inhibition of autophagy by 3MA 
blocked the H3K4 trimethylation at IL-6 and TNF-α promoters in BCG-trained monocytes 
(Figure 5C-D), supporting the hypothesis of a central role of autophagy in the epigenetic 
reprogramming of monocytes induced by BCG.
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Discussion 
BCG is a live attenuated vaccine which is routinely administered at birth in low-income 
countries, protecting newborns against disseminated tuberculosis and tuberculosis 
meningitis [14]. However, in addition to its specific protection against childhood 
tuberculosis, epidemiological studies have demonstrated that BCG protects against infant 
mortality independent of its effect on tuberculosis, suggesting a nonspecific protection 
against unrelated infections [15-24]. Next to that, BCG treatment has long been used as 
a non-specific immunostimulatory therapy in urothelial cell carcinomas [25]. Recently, 
these non-specific protective mechanisms of BCG have been associated with epigenetic 
reprogramming of innate immune cells in a process called trained immunity [7]. In the 
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Figure 5. Impairment of autophagy decreases trimethylation at H3K4 in human monocytes. ChIP analysis of 
the enrichment of H3K4me3 at the promoter of (A) TNF-α and (B) IL-6 in human monocytes isolated from volunteers 
carrying the major variant (GG) or minor variant (CC) alleles for ATG2B after training with BCG. ChIP analysis of the 
enrichment of H3K4me3 at the promoter of (C) TNF-α and (D) IL-6 in human monocytes trained with BCG in the 
presence or absence of 3MA *p<0.05, **p<0.01.
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present study we show that autophagy is a central event modulating trained immunity 
induced by BCG. Moreover, polymorphisms in autophagy genes such as ATG2B control 
trained immunity in both in vitro and in vivo models, as well as the non-specific therapeutic 
effects of BCG in patients with bladder cancer.
An important difference has to be noted between the effect of ATG2B polymorphism on 
BCG training against secondary infections and BCG used as a treatment against non-
muscle invasive bladder cancer. BCG training of monocytes against unrelated secondary 
infections could only be modulated by an ATG2B polymorphism expressed on both 
alleles. Heterozygote individuals were still trainable with the vaccine. On the contrary, the 
prognosis in terms of recurrence and progression of non-muscle invasive bladder cancer 
decreased with only one affected allele. The different route of BCG administration, as 
well as several disease-related mechanisms could be the explanation of this event. To 
further unravel the different mechanisms behind this phenomenon, a pilot study has been 
performed to investigate whether BCG installation in the bladder could induce a state of 
trained immunity. The cytokine response of ex-vivo stimulated monocytes of BCG treated 
bladder cancer patients increased in response to LPS compared to the pre-treatment 
response.
In addition to the aspects discussed above, there are also a few limitations of the 
current study. Thus, although we demonstrate the role of autophagy for BCG-induced 
trained immunity, additional studies are needed to decipher the precise pathway linking 
autophagy to the epigenetic modifications observed during trained immunity. A second 
important aspect is the fact that the genetic study has been performed in a relatively small 
cohort of patients with bladder carcinoma, and it needs to be validated by independent 
studies. Finally, the role of autophagy gene SNPs for the effects of BCG on infections 
also needs to be evaluated. The role of BCG for protection against infection is currently 
investigated by a large Danish study in 4500 newborn children (http://calmette-studiet.
dk/), and the effect of the autophagy polymorphisms on the effects of BCG is an important 
aspect to be assessed.
A key question regarding trained immunity refers to the signaling and molecular 
mechanisms responsible for its induction. As shown previously, exposure of monoctyes 
to BCG induces high levels of H3K4 trimethylation at the promoter level of inflammatory 
genes, which correlates with long-term increased production of proinflammatory 
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cytokines, a hallmark of trained immunity [6,7].  Next to that, the blockage of histone 
acetyltransferases inhibits the training of monoctyes [26] suggesting also an important 
role of acetylation in trained immunity which will be further studied in the future.
The discovery that autophagy modulates trained immunity may have important 
consequences. It provides understanding of an important immunological process, 
although future studies are warranted to identify the molecular mechanisms through 
which autophagy mediates the epigenetic changes responsible for trained immunity. 
Restriction of reactive oxygen species release from damaged mitochondria, or processing 
of microbial ligands such as peptidoglycans [9], may represent two potential candidate 
mechanisms. Furthermore, identification of autophagy as a driver of trained immunity 
opens new possibilities for improvement of future BCG-based vaccines to be used against 
infections and malignancies.
Materials and Methods
Ethics statement. All human experiments were conducted according to the principles 
expressed in the Declaration of Helsinki. Before taking blood, informed written consent 
of each human subject was obtained. The study was approved by the review board of 
the department of Medicine of the Radboud University Nijmegen Medical Centre. The 
BCG in vivo study was approved by the Arnhem-Nijmegen Ethical Committee. For the 
NBCS, all participants gave written informed consent and the study was approved by the 
Institutional Review Board of the RUMC. All data analyzed were anonymized.
Healthy volunteers. In vitro cytokine stimulation experiments were performed with 
PBMCs isolated from buffy coats obtained from healthy volunteers (Sanquin Bloodbank, 
Nijmegen, the Netherlands). To analyze the effect of gene polymorphisms on trained 
immunity, blood was drawn from a group of healthy volunteers (age 23-73). For the in vivo 
BCG model, subjects (aged 20-36) who were scheduled to receive a BCG vaccination at 
the public health service, due to travel or work in tuberculosis-endemic countries, were 
asked to participate in this trial. Blood was drawn before and 3 months after the BCG 
vaccination. Informed consent was obtained from all human subjects.
The bladder cancer patients included in this study were selected from a total of 1,602 
patients with primary urinary bladder cancer (UBC) from the Nijmegen Bladder Cancer 
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Study (NBCS). The NBCS served as the Dutch discovery population in the UBC genome-
wide association study led by Radboud University Medical Centre (RUMC, Nijmegen, the 
Netherlands) and deCODE Genetics (Reykjavik, Iceland). The NBCS has been described 
in detail before [27]. Cases with a previous or simultaneous diagnosis of upper urinary 
tract cancer, based on information from the Netherlands Cancer Registry, were excluded. 
Detailed clinical data concerning diagnosis, stage, treatment, and disease course (tumor 
recurrence and progression) were collected retrospectively based on a medical file 
survey. In the analysis we included a total of 192 cases with non-muscle invasive bladder 
cancer (NMIBC; stage Ta/T1/CIS) that received at least 6 intravesical BCG instillations 
as initial treatment (median follow-up time from initial transurethral resection of bladder 
tumor until last urological check-up visit was 5.2 years (range: 0.4 - 20)). All patients were 
from Caucasian background.
Microorganisms. C. albicans ATCC MYA-3573 (UC 820) yeast was heat-inactivated for 
30 min at 95°C. B. burgdorferi, ATCC strain 35210, was cultured at 33°C in Barbour-
Stoenner-Kelley (BSK)-H medium (Sigma-Aldrich) supplemented with 6% rabbit serum. 
Spirochetes were grown to late-logarithmic phase and examined for motility by dark-field 
microscopy. Bacteria were harvested by centrifugation of the culture at 7000 x g for 15 
min and washed twice with sterile PBS (pH 7.4).
Stimulation experiments. The mononuclear cell fraction was obtained by density 
centrifugation of blood diluted 1:1 in pyrogen-free saline over Ficoll-Paque (Pharmacia 
Biotech, Pittsburgh, Pennsylvania, USA). Cells were washed twice in saline and resuspended 
in culture medium (RPMI; Invitrogen, Carlsbad, California, USA) supplemented with 50 
mg/L gentamicin, 2 mM L-glutamine and 1 mM pyruvate. PBMCs were counted in a Coulter 
counter (Coulter Electronics, Brea, California, USA) and their number was adjusted to 5 x 
106 cells / ml.  A total of 5 x 105 cells in a 100 μl volume was added to round-bottom 96-well 
plates (Greiner) with RPMI, E. coli LPS (10 ng/ml) or B. burgdorferi (1 x 106 /ml). After 24h, 
the supernatants were collected and stored at -20°C until being assayed.
For training experiments, PBMCs (5 x 105 for cytokine analysis; 10 x 106 for ChIP analysis) 
were incubated for 1 h at 37°C in 5% CO2. Adherent monocytes were selected by washing 
out nonadherent cells with warm PBS. Thereafter, cells were preincubated with RPMI, 
BCG vaccine (1 μg/ml BCG vaccine SSI from the Netherlands Vaccine Institute) or β-1,3-
(D)-glucan (β-glucan) (10 ng/ml; kindly provided by Professor David Williams) for 24 h 
(4h for Real-time PCR). After a resting period of 6 d in RPMI including 10% serum, cells 
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were stimulated with E. coli LPS (10 ng/ml), C. albicans (1 x 106 /ml), B. burgdorferi (1 x 
106 /ml), or RPMI for an additional 24h. Supernatants were stored at -20°C until ELISA 
was performed.  In the “inhibition” experiments, before training with BCG or β-glucan, 
the adherent monocytes were preincubated for 1 h with 10mM 3-methyl adenine (3MA, 
Sigma).
Cytokine measurements. Concentrations of human IL-1β, IL-6 and TNF-α were 
determined in duplicates using commercial ELISA kits (Sanquin, Amsterdam, or R&D 
Systems, Minneapolis), in accordance with the manufacturers’ instructions.
Real-time PCR. RNA from stimulated monocytes was isolated using TRIzol reagent 
(Invitrogen) according to the manufacturer’s instructions. Isolated RNA was reverse-
transcribed into complementary DNA using iScript cDNA synthesis kit (Bio-Rad). 
Quantitative real-time PCR was performed using Power SYBR Green PCR Master Mix 
(Applied Biosystems) using a 7300 Real-time PCR system (Applied Biosystems). In each 
PCR a melting curve analysis was included to control for a specific PCR amplification. 
Primers used for the experiments (final concentration 10 μM) are shown below. Real-
time quantitative PCR data were corrected for expression of the housekeeping 
gene B2M. Human ATG2B forward: ACCAGAGATAGCACCTTCTGAC and reverse: 
CCAATTAACCGTCCAATCTG; human B2M forward: ATGAGTATGCCTGCCGTGTG and 
reverse: CCAAATGCGGCATCTTCAAAC.
Isolation of genomic DNA and single nucleotide polymorphism analysis. In 
vitro training experiment: Using NCBI SNP database we selected SNPs in autophagy 
genes previously associated to diseases or with a minor allele frequency of at least 5% 
(ATG10 (rs1864183), ATG10 (rs3734114), ATG16L1 (rs2241880), ATG2B (rs3759601) 
[allele frequency: G = 70%; C = 30%], ATG5 (rs2245214), EREG (rs78803121), IRGM 
(rs4958847), LAMP3 (rs482912), WIPI (rs883541)). Blood samples were obtained by 
venapuncture. Genomic DNA was isolated from EDTA blood using standard methods, 
and 5 ng of DNA was used for genotyping. Multiplex assays were designed using 
Mass ARRAY Designer Software (Sequenom) and genotypes were determined using 
Sequenom MALDI-TOF MS according to manufacturer’s instructions (Sequenom Inc., 
San Diego, CA, USA) as described previously [28].
In vivo BCG-cohort: DNA was isolated using the Gentra Pure Gene Blood kit (Qiagen), 
in accordance with the manufacturer’s protocol for whole blood. DNA was dissolved in a 
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final volume of 100 μl buffer. Genotyping of single nucleotide polymorphisms (SNPs) was 
performed using a pre-designed TaqMan H SNP genotyping assay (Applied Biosystems) 
according to the manufacturer’s protocol.
NBCS: All bladder cancer patients were genotyped using the Illumina Infinium 
HumanCNV370-duo Bead-Chips. Imputation was performed (IMPUTE version 2.1 
software) using the 1000 Genomes low-coverage pilot haplotypes (released June 
2010, 120 chromosomes) and the HapMap3 haplotypes (released February 2009, 1920 
chromosomes) as a combined reference panel[27]. SNP rs3759601 was imputed with 
IMPUTE info_score 0.99. The SNP followed Hardy-Weinberg equilibrium.
Transcriptome analysis. Gene expression was performed as described previously[29] 
and assessed using Illumina Human HT-12 Expression BeadChip according to 
manufacturer’s instructions. The Illumina LIMS platform, BeadStudio was employed to 
perform image analysis, bead-level processing, and quantile normalization of array data.
Chromatin immunoprecipitation. Adherent monocytes were cultured as described above 
(see Stimulation Experiments). ChIP was performed using antibodies against H3K4me3 
(Diagenode). ChIPed DNA was processed further for qPCR analysis. The following primers were 
used in the reaction (5’-3’): TNF-α forward: CAGGCAGGTTCTCTTCCTCT, TNF-α reverse: 
GCTTTCAGTGCTCATGGTGT; IL-6 forward: TCGTGCATGACTTCAGCTTT, IL-6 reverse: 
GCGCTAAGAAGCAGAACCAC; myoglobin forward:  AGCATGGTGCCACTGTGCT, 
myoglobin reverse: GGCTTAATCTCTGCCTCATGAT.
Immunofluorescence staining. For immunofluorescence imaging, monocytes were 
seeded on coverslips pretreated with polylysine, fixed with 4% PFA for 15 min at room 
temperature followed by 10 min of fixation with ice-cold methanol at -20°C. After two 
washing steps with PBS, cells were permeabilized by 0.1% saponin (Sigma-Aldrich), 
blocked for 30 min in PBS plus 2% BSA, incubated for 1 h with a mouse mAb to LC3 (1:50; 
Nanotools), washed twice in PBS plus 2% BSA and stained by a secondary Alexa Fluor 
555 goat anti-mouse Ab (1:500; Molecular Probes), followed by DNA staining with 10µM 
TO-PRO-3 iodide (642/661; Invitrogen). After the washing steps, slides were mounted in 
Prolong Gold antifade media (Molecular Probes). Images were acquired using a laser-
scanning spectral confocal microscope (TCS SP2; Leica Microsystems) and LCS Lite 
software (Leica microsystems). 2 fields / donor including at least 40 cells each were 
counted and compared for the amount of LC3.
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Statistical analysis. Data are expressed as mean ± SEM unless mentioned otherwise. 
Differences between experimental groups were tested using the non-parametrical two-
sided Mann-Whitney U test (no normal distribution of measured cytokines); differences 
between multiple time points within one group (before versus after treatment) were tested 
using the Wilcoxon matched pair test (unless stated otherwise) performed on GraphPad 
Prism 4.0 software (GraphPad). P values of ≤0.05 were considered statistically significant.
Kaplan-Meier survival and Cox proportional hazard regression analyses were performed 
to evaluate the association between rs3759601 and recurrence- and progression-free 
survival. Log-rank tests were calculated to compare survival curves between genotype 
categories. Imputed genotype probabilities were transformed to hard genotype calls 
based on a probability threshold of > 0.90. Statistical analyses were performed using IBM 
SPSS Statistics for Windows 20 (IBM Corp., Armonk, NY, USA) and survival plots were 
drawn using R software v3.0.2 (package ‘survival’) (R Development Core Team, Vienna, 
Austria).
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Figure S1. Role of autophagy for the training of monocytes. BCG (A-B, E-F) or β-glucan (C-D, G-H) training in 
vitro in the presence or absence of 3MA or wortmannin using freshly isolated human monocytes and different stimuli 
for restimulation (LPS, B. burgdorferi). TNF-α (A-D) and IL-6 (E-H) were assessed by ELISA in the supernatants. 
*P<0.05, **P<0.01.
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Figure S2. Viability of monocytes after chemical blocking of autophagy for 24h. BCG or β-glucan training in 
vitro in the presence or absence of 3MA or wortmannin using freshly isolated human monocytes. Cell viability tested 
by CytoTox 96 NonRadioactive Cytotoxicity Assay after 24h (A), 3 days (B) and 6 days (C).
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Figure S3. Polymorphisms in ATG10, ATG16L1, EREG, IRGM, LAMP3 and ATG18 do not diminish the training 
capacity of human monocytes. Blood was collected from volunteers and genotyped for ATG10 rs1864183 and 
rs3734114 (A-D), ATG16L1 rs2241880 (E-F), EREG rs78803121 (G-H), IRGM rs4958847 (I-J), LAMP3 rs482912 
(K-L) and ATG18 rs8835411 (M-N). Human monocytes were trained with BCG for 24 h, washed and incubated in 
RPMI (10% human serum) for 6 d, after which they were restimulated for 24h with a second stimulus (LPS or Bb). 
Proinflammatory cytokine production (TNF-α) was assessed by ELISA in the supernatants.
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Figure S4. SNP in ATG2B affects its expression after training but not stimulation. Human monocytes carrying 
different genotypes for SNP rs3759601 were trained with β-glucan [A] or stimulated with LPS [B] for 4h. Expression 
of ATG2B was assessed by qPCR.
Figure S5. SNP in ATG2B affects the efficacy of in vivo BCG-induced trained immunity. Monocytes isolated 
before and 3 months after vaccination of 16 naïve (nonexposed) volunteers were stimulated in vitro with LPS. 
Proinflammatory cytokine production (IL-1β [A], TNF-α [B]) was assessed by ELISA in the supernatants.
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Chapter 7
Summary and general conclusion
Lyme disease, caused by spirochetes of the Borrelia burgdorferi sensu lato complex, 
is the most common vector-born disease in the northern hemisphere. The disease was 
diagnosed as a separate condition for the first time in Old Lyme, Connecticut in 1975 
followed by the description of the bacterium involved in 1981 by Willy Burgdorfer [1, 2]. 
The knowledge about B. burgdorferi has increased significantly in the last three decades. 
The transmission of the bacterium takes place after the attachment of an infected Ixodes 
tick. After B. burgdorferi is injected into the skin by an infected tick, the host’s immune 
system induces a rapid inflammatory response [3].
As an introduction to this thesis, we explored the signaling pathways involved in the 
recognition of B. burgdorferi by immune cells and their effect on the induction of cytokines 
in Chapter 2. Using several knockout mice, we were able to investigate the role of TLR-, 
NLR- and IL-1 signaling during the stimulation with B. burgdorferi. Murine macrophages 
lacking the IL-1 receptor expressed an abrogated cytokine response to the spirochete 
illustrating the important role of IL-1 during murine Lyme arthritis. In addition, we reported 
a critical role of the TLR2-Myd88 pathway activating Caspase-1 which is responsible for 
the cleavage of inactive pro-IL-1β into its active form. Although NOD2 has been shown 
to play an important role on the induction of pro-inflammatory cytokines after Borrelia 
recognition in humans, NOD1 and NOD2 seem to be redundant in the investigated 
murine model.
NOD2 is a receptor which has been associated with the induction of the intracellular 
degradation process called autophagy [4]. Since autophagy has been linked to the 
modulation of cytokine production in several diseases [5], we investigated its role on 
Borrelia-induced cytokines in Chapter 3. First, we demonstrated the induction of autophagy 
by the spirochete. In addition, by stimulating human peripheral blood mononuclear cells 
(PBMCs), we proved that inhibition of autophagy increased pro-inflammatory innate 
cytokines after stimulation with Borrelia bacteria. Since previous studies have shown that 
autophagy modulated the production of T-cell derived cytokines [6] and elevated levels of 
IL-17 have been found in patients with confirmed neuroborreliosis [7], we investigated the 
role of autophagy on Borrelia-induced adaptive cytokines in Chapter 4. Higher levels of 
IL-17, IL-22 and IFN-γ protein were found in autophagy-blocked PBMCs stimulated with 
the Borrelia-spirochete, demonstrating a regulatory link between autophagy and T-cell 
cytokine production in response to B. burgdorferi stimulation.
7
Chapter 7
130
Assessment of clinical symptoms and immune characteristics of Borrelia-infected patients 
illustrates a large diversity in clinical symptoms which have been associated to genetic 
variations in these patients leading to differences in clinical outcome [8]. In Chapter 5, 
we investigated the role of genetic variations in autophagy genes and their effect on 
Borrelia-induced cytokine responses. Significant up- and downregulation of several 
autophagy-related genes as ATG7, ATG9, and ATG16L1 was found in PBMCs exposed to 
B. burgdorferi. Different expression levels of those genes could also be found comparing 
Lyme disease patients to healthy controls indicating a relevant role for those genes in 
the pathogenesis of the disease. In addition, we looked into the effect of differentially 
expressed autophagy-related genes on the production of inflammatory cytokines. Single 
nucleotide polymorphisms (SNPs) in autophagy genes modulating the expression of 
inflammatory cytokines could be one explanation for the different disease outcome.
In recent years, emerging evidence has shown that after infection or vaccination, innate 
immune cells display long-term changes in their functional programs. These changes 
lead to increased production of inflammatory mediators and enhanced capacity to 
eliminate infection [9]. In Chapter 6 the role of autophagy in this process, called trained 
immunity, has been investigated. Polymorphisms in autophagy genes such as ATG2B 
and ATG5 control trained immunity in vitro and in vivo. Borrelia-stimulated monocytes 
from volunteers carrying an ATG polymorphism produced the same amount of cytokines 
before and after vaccination in contrast to wildtype monocytes which produced elevated 
levels of IL-1β three months post-vaccination. A vaccination with BCG could therefore 
have a protective role for future infections with B. burgdorferi in individuals with intact 
autophagy. 
General conclusion and future perspectives
The incidence of Lyme disease has increased in the past few years, pointing to the urgency 
of new developments in treatment options. The Infectious Diseases Society of America 
published guidelines for the treatment of Lyme disease including oral antibiotics as a first 
line therapy and intravenously-applied antibiotics for patients with more severe symptoms 
[10]. Nevertheless, in approximately 10% of the patients symptoms may persist [11]. The 
reason for persistent symptoms in some patients after treatment for Lyme disease is not 
known. Theories include residual damage to tissue, slow resolution of the inflammatory 
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state, or a form of cytokine-induced sickness behavior due to previously high levels of 
circulating cytokines [12].
In this thesis, we studied the effect of autophagy on Lyme disease in order to provide 
novel strategies for the treatment of the disease. We have demonstrated the induction 
of autophagy by Borrelia burgdorferi and its regulatory function on the production of 
Borrelia-induced cytokines. It is tempting to speculate that inhibition of autophagy could 
be beneficial during the early phase of Lyme disease leading to a higher concentration of 
innate cytokines and therefore a possibly improved clearance of the pathogen. However, 
because Lyme disease occurs in different stadia, enhanced IL-1β production by autophagy 
modulation in disseminated Lyme disease might be detrimental for the disease activity. 
Several studies indicated a link between a high concentration of IL-1β and pathogenic 
Th17 cells leading to increased joint damage in rheumatoid arthritis [13]. Therefore, the 
induction of autophagy in the disseminated state of Lyme disease could be favorable 
for Lyme patients through a decreased IL-1β production and inhibition of pathogenic 
Th17 cells. In the future, it might be possible to test patients for their intrinsic autophagy 
potential and adapt treatment options according the stadium of the disease and the status 
of their autophagy capability. Our findings underline the important role of autophagy in 
the pathogenesis of Lyme disease and suggest that modulation of autophagy could be a 
novel therapeutic strategy in that disease. 
In the last chapter of this thesis, we studied the effect of autophagy on trained immunity 
induced by BCG. Emerging evidence has shown that after infection or vaccination, innate 
immune cells display long-term changes in their functional programs. These changes lead 
to increased production of inflammatory mediators and enhanced capacity to eliminate 
infection. 
We discovered that autophagy is a central event modulating trained immunity induced by 
BCG which opens new possibilities for improvement of future BCG-based vaccines to be 
used against infections such as Lyme Disease. The addition of an autophagy-inducing 
agent to the vaccine could lead to improved trained immunity, and therefore an enhanced 
therapeutic potential.
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Chapter 8
Nederlandse samenvatting en conclusie
De ziekte van Lyme, veroorzaakt door bacteriën van het Borrelia burgdorferi sensu lato 
complex, is de meest verspreide vector-veroorzaakte ziekte in de noordelijke hemisfeer. 
De ziekte werd voor het eerst gediagnosticeerd in Old Lyme, Connecticut, in het jaar 1975 
gevolgd door de beschrijving van de bacteriën in het jaar 1981 door Willy Burgdorfer. De 
kennis over Borrelia is toegenomen in de afgelopen drie decennia. Besmetting met deze 
bacterie vindt plaats nadat een geïnfecteerde teek meer dan 24 uur heeft vastgezeten op 
de huid. Nadat de pathogeen in de gastheer terecht komt, induceert het afweersysteem 
zeer snel een immuunrespons tegen Borrelia. 
Als inleiding van dit proefschrift hebben wij de signaalwegen die betrokken zijn bij de 
herkenning van Borrelia door immuuncellen onderzocht (Hoofdstuk 2). We hebben de 
rol van Toll-like receptors (TLR),  NOD-like receptors (NLR), en IL-1 signalen bestudeerd 
in een muismodel met Lyme artritis, door gebruik te maken van verschillende knock-out 
muizen. Wanneer macrofagen van muizen, die IL-1 receptor moleculen mistten, werden 
gestimuleerd met Borrelia spirocheten, werd een verlaging van de cytokineproductie 
waargenomen. We rapporteerden ook een belangrijke rol voor de TLR2-Myd88 cascade 
voor de activering van caspase-1, een molecuul dat verantwoordelijk is voor het splitsen 
van pro-IL-1β in zijn actieve vorm. Hoewel NOD2 een belangrijke rol speelt tijdens de 
inductie van humaan pro-inflammatoire cytokines na de herkenning van Borrelia bacterie, 
schijnen NOD1 en NOD2 overbodig te zijn in ons muismodel.
NOD2 is een receptor die onder andere met de inductie van intracellulaire 
degradatieprocessen, ook autofagie genoemd, wordt geassocieerd. Omdat autofagie met de 
modulatie van cytokinenproductie in verschillende ziektes wordt verbonden, hebben wij de 
rol van autofagie op Borrelia-geïnduceerde cytokinenproductie onderzocht (Hoofdstuk 3). 
Ten eerste hebben wij de inductie van autofagie door Borrelia laten zien. Bovendien konden 
wij door de stimulatie van humane perifere bloed mononucleaire cellen (PBMCs) aantonen 
dat het remmen van autofagie de Borrelia-afhankelijke cytokinenproductie verhoogd. 
Eerdere studies hebben laten zien dat autofagie de productie van T-cel afhankelijke 
cytokines kan moduleren en verhoogde hoeveelheden van IL-17 werden in patiënten met 
neuroborreliose gevonden. Dat was voor ons de reden om de rol van autofagie op Borrelia-
geïnduceerde adaptieve cytokines te onderzoeken (Hoofdstuk 4). Hoge levels van IL-17, 
IL-22 en IFN-γ konden wij aantonen in Borrelia-gestimuleerde PBMCs waarbij autofagie 
geblokkeerd was. Dit laat een regulatorische link zien tussen autofagie en de productie van 
T-cel cytokines na stimulatie van afweercellen met deze bacteriën.
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Het vastleggen van klinische symptomen en eigenschappen van de afweerreactie van 
patiënten die met Borrelia-bacteriën geïnfecteerd zijn laat een grote diversiteit zien van 
klinische verschijnselen die geassocieerd zijn met genetische variatie. Deze diversiteit 
leidt ook tot verschillen in succes van de behandeling. In Hoofdstuk 5 hebben wij de 
rol van genetische variatie van autofagie genen en het effect op Borrelia-geïnduceerde 
cytokinenproductie onderzocht. Significante veranderingen van meerdere autofagie-
genen zoals ATG7, ATG9, en ATG16L1 werden gevonden in PBMCs die met Borrelia 
werden gestimuleerd. Verschillende expressie hoeveelheden van deze genen werden 
gevonden als patiënten monsters met monsters van gezonde vrijwilligers werden 
vergeleken. Dit resultaat laat een relevante rol van deze genen in de pathogenese van de 
ziekte van Lyme zien. Het effect van polymorfismen in autofagie genen op de expressie 
van inflammatoire cytokines zou een mogelijke verklaring voor verschillen in ziektebeeld 
kunnen zijn.
In recente jaren hebben verschillende studies aangetoond dat vroege afweercellen 
langdurige veranderingen in hun afweerfuncties hebben door een infectie of een 
vaccinatie. Deze veranderingen leiden tot een verhoogde productie van inflammatoire 
mediatoren en een verhoogde capaciteit om een infectie te stoppen. In Hoofdstuk 6 werd 
de rol van autofagie op dit proces, trained immunity genoemd, onderzocht. Polymorfismen 
in autofagiegenen zoals ATG2B en ATG5 controleren trained immunity in vitro en in 
vivo. Borrelia-gestimuleerde monocyten van vrijwilligers met een ATG polymorfisme 
produceren dezelfde hoeveelheid cytokines voor en na een vaccinatie in tegenstelling tot 
wildtype monocyten die een hogere hoeveelheid IL-1β produceren drie maanden na de 
vaccinatie. Een vaccinatie met BCG zou daarom een beschermende rol voor een latere 
infectie met Borrelia kunnen hebben in mensen met een intact autofagie-systeem. 
Algemene conclusies en toekomstperspectieven
De incidentie van de ziekte van Lyme is toegenomen in de afgelopen jaren en wijst op 
de urgentie van nieuwe ontwikkelingen van behandelingen. De ‘Infectious Diseases 
Society of America’ heeft nieuwe richtlijnen van behandelingen tegen de ziekte van 
Lyme gepubliceerd. Orale antibiotica worden na de eerste symptomen voorgeschreven. 
Voor patiënten met ernstigere verschijnselen worden antibiotica voorgeschreven die in 
het bloed worden toegediend. Desondanks houdt 10% van de patiënten klachten na 
behandeling. De oorzaak van aanhoudende verschijnselen van sommige patiënten na 
de behandeling is niet bekend. Verschillende theorieën beweren dat dit verschillende 
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oorzaken kan hebben, waaronder rest-schade aan weefsels, een langzame verdwijning 
van het ontstekingsproces of een vorm van ziekte geïnduceerd door aanwezigheid van 
hoge concentraties van cytokines tijdens de ontsteking.
In dit proefschrift hebben wij het effect van autofagie op de ziekte van Lyme onderzocht 
om nieuwe strategieën voor de behandeling van deze ziekte te vinden. Wij konden 
inductie van autofagie door Borrelia laten zien, maar ook de regulatorische functie van 
autofagie op de productie van Borrelia-geïnduceerde cytokines. Wij speculeren dat de 
remming van autofagie belangrijk zou kunnen zijn in de eerste fase van de ziekte omdat 
een hogere concentratie van vroege cytokines door de remming van autofagie word 
geproduceerd, wat de eliminatie van het pathogeen zou bespoedigen. De ziekte van 
Lyme heeft verschillende stadia; verhoogde productie van IL-1β zou nadelig kunnen zijn 
in een later stadium van de ziekte. Inductie van autofagie zou voordelig kunnen zijn voor 
Lyme patiënten in een later stadium van de ziekte omdat een verlaagde productie van 
IL-1β een verlaagde hoeveelheid Th17 cellen ten gevolge heeft. In de toekomst zou het 
mogelijk kunnen zijn om patiënten op de werking van autofagie te kunnen testen en 
behandelingen aan te passen op het stadium van de ziekte en de staat van autofagie. 
Onze resulaten onderschrijven de belangrijke rol van autofagie tijdens te pathogenese 
van de ziekte van Lyme en suggereerd dat modulatie van autofagie een potentiële nieuwe 
behandelingsoptie voor deze ziekte zou kunnen zijn.
In het laatste hoofdstuk van dit proefschrift hebben wij het effect van autofagie op “trained 
immunity” onderzocht. Nieuw onderzoek heeft laten zien dat vroege immuuncellen na 
infectie of vaccinatie langdurige veranderingen oplopen. Deze veranderingen leiden tot 
een verhoogde productie van inflammatoire mediatoren en een verhoogde capaciteit om 
infecties te stoppen.
Wij hebben ontdekt dat autofagie een centrale rol speelt bij de modulatie van trained 
immunity geïnduceerd door BCG. Dit biedt nieuwe mogelijkheden voor verbeteringen in 
toekomstige BCG-gebaseerde vaccinaties die gebruikt kunnen worden tegen infecties 
zoals de ziekte van Lyme. Het toevoegen van een autofagie-inducerende stof zou de 
training van de afweercellen na de vaccinatie kunnen bevorderen, en op deze manier de 
effectiviteit van de vaccinatie te verhogen.
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